[{"Date":"2007-11-09T00:00:00.000","Headline":"S&P Picks and Pans: Qualcomm, Wachovia, Fannie, Merck, Lennar","Summary":"Analyst opinions on stocks making headlines Friday"},{"Date":"2007-11-09T00:00:00.000","Headline":"What Merck Gains by Settling","Summary":"The pharmaceutical powerhouse enjoys a shot in the arm to its stock after putting its Vioxx litigation to rest. Now it can focus on bringing new drugs to market"},{"Date":"2007-11-19T00:00:00.000","Headline":"German Stocks Including Postbank Advance; Allianz Leads Falls","Summary":"German stocks including Deutsche Postbank AG advanced after Frankfurter Allgemeine Zeitung reported the country's largest bank by clients may be sold. Allianz SE, Europe's biggest insurer, led declining shares."},{"Date":"2007-11-19T00:00:00.000","Headline":"Adva, Infineon, Postbank, Software AG: German Equity Preview","Summary":"The following stocks may rise or fall in German markets. Stock symbols are in parentheses after the company names and prices are from the last Xetra close unless otherwise stated."},{"Date":"2007-11-19T00:00:00.000","Headline":"German Stocks Decline; Allianz, Munich Re, TUI Lead the Retreat","Summary":"German stocks dropped for a third day. Allianz SE, Europe's largest insurer, and Munich Re led financial stocks lower."},{"Date":"2007-11-26T00:00:00.000","Headline":"Out from Under Vioxx","Summary":"Merck (MRK) found an antidote to the pain of Vioxx, its recalled arthritis drug that sparked 27,000 liability lawsuits. On Nov. 9, the pharma giant reversed its former pledge to fight each case aggressively and announced it would pay $4.85 billion to settle the suits. Industry experts say the accord could provide a template for future liability cases. Patients wishing to claim some of the cash face a high burden of proof that Vioxx caused their injuries. The deal limits Merck's exposure to futur"},{"Date":"2007-11-27T00:00:00.000","Headline":"Are Stocks Signaling a Recession?","Summary":"Not necessarily; market slides don't always mean economic rout. Still, S&P offers defensive strategiesand stock picksfor antsy investors"},{"Date":"2007-11-28T00:00:00.000","Headline":"Metro, Douglas, Porsche, Schmack, Tognum: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses after company names. Share prices are from the last close."},{"Date":"2007-12-04T00:00:00.000","Headline":"Movers: Merck, H&R Block, Nokia, Delta","Summary":"Tuesday's stocks in the news"},{"Date":"2007-12-04T00:00:00.000","Headline":"S&P Picks and Pans: eBay, Merck, Delta, Dow Chemical, LUV","Summary":"Analyst opinions on stocks making headlines Tuesday"},{"Date":"2007-12-04T00:00:00.000","Headline":"Stocks Fall on Profit Worries","Summary":"Lower forecasts for corporate earnings -- and an analyst downgrade of investment banking shares --weighed on the market Tuesday"},{"Date":"2007-12-05T00:00:00.000","Headline":"The Logic of Biotech Bets","Summary":"Big Pharma is investing big in targeted, biologically derived drugs, not least because they're safe from generic competitionfor now"},{"Date":"2007-12-06T00:00:00.000","Headline":"Bristol-Myers Shrinks","Summary":"Big Pharma keeps getting smaller. Bristol-Myers Squibb (BMY) is the latest member of the club to announce downsizing: It said on Dec. 5 that it will cut 10% of its 43,000 employees and close half its plants, saving $1.5 billion in costs. Abbott Labs (ABT), Pfizer (PFE), and Merck (MRK) are already trying to slim down."},{"Date":"2007-12-06T00:00:00.000","Headline":"Is Alzheimer's a Form of Diabetes?","Summary":"If so, an insulin-centered treatment could alter the course of the disease"},{"Date":"2007-12-11T00:00:00.000","Headline":"Stocks: Bernanke Plays Scrooge","Summary":"Disappointment with the central bank's moves -- especially its quarter-point discount rate easing -- sparked a sell-off Tuesday"},{"Date":"2007-12-11T00:00:00.000","Headline":"Movers: Freddie Mac, GE, Citigroup, Washington Mutual, AT&T","Summary":"Tuesday's stocks in the news"},{"Date":"2007-12-12T00:00:00.000","Headline":"Coca-Cola Enterprises, MGIC, Office Depot: U.S. Equity Movers","Summary":"The following is a list of companies whose shares are having unusual price changes on U.S. exchanges. Stock symbols are in parentheses after company names and prices are as of 11:40 a.m. in New York."},{"Date":"2007-12-12T00:00:00.000","Headline":"Movers: SLM, NetManage, Bank of America, Office Depot, International Speedway","Summary":"Wednesday's stocks in the news"},{"Date":"2007-12-28T00:00:00.000","Headline":"The Top European Business Stories of 2007","Summary":"The year saw no shortage of political and corporate drama. Here are some of the highlights of a topsy-turvy 2007"},{"Date":"2008-01-14T00:00:00.000","Headline":"S&P Picks and Pans: IBM, Merck, Sears, Merrill, Sovereign, EMC","Summary":"Analyst opinions on stocks making headlines in Monday's market"},{"Date":"2008-01-14T00:00:00.000","Headline":"ASV, Bright Horizons, FTD, Harman, Openwave: U.S. Equity Movers","Summary":"The following is a list of companies whose shares are having unusual price changes in U.S. exchanges. Stock symbols are in parentheses after company names and prices are as of 10:10 a.m. in New York."},{"Date":"2008-01-14T00:00:00.000","Headline":"Coach, FCStone, Juniper, Kirby, Openwave: U.S. Equity Movers","Summary":"The following is a list of companies whose shares are having unusual price changes in U.S. exchanges. Stock symbols are in parentheses after company names and prices are as of 2:40 p.m. in New York."},{"Date":"2008-01-17T00:00:00.000","Headline":"Do Cholesterol Drugs Do Any Good?","Summary":"Research suggests that, except among high-risk heart patients, the benefits of statins such as Lipitor are overstated"},{"Date":"2008-01-25T00:00:00.000","Headline":"DeVry, E-Trade, Federal Signal, Merck: U.S. Equity Movers Final","Summary":"The following is a list of companies whose shares had unusual price changes in the U.S. Stock symbols are in parentheses after company names and prices are as of 4 p.m. in New York."},{"Date":"2008-01-25T00:00:00.000","Headline":"Horizon, Hovnanian, Merck, WellCare Health: U.S. Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in U.S. exchanges on Jan. 28. Stock symbols are in parentheses after company names."},{"Date":"2008-01-28T00:00:00.000","Headline":"Black & Decker, Corning, Sears, WellCare: U.S. Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in the U.S. Stock symbols are in parentheses after company names and prices are as of 7:30 a.m. in New York."},{"Date":"2008-01-28T00:00:00.000","Headline":"Acorda, Alliance Data, McDonald's, SLM: U.S. Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in the U.S. Stock symbols are in parentheses after company names and prices are as of 8:55 a.m. in New York."},{"Date":"2008-01-30T00:00:00.000","Headline":"Kraft, Legg Mason, Merck, Websense, UBS: U.S. Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in U.S. markets. Stock symbols are in parentheses after company names, and prices are as of 8:10 a.m. in New York."},{"Date":"2008-01-30T00:00:00.000","Headline":"Centex, CyberSource, Tupperware, Wolverine: U.S. Equity Movers","Summary":"The following is a list of companies whose shares are having unusual price changes in U.S. markets. Stock symbols are in parentheses after company names, and prices are as of 10:10 a.m. in New York."},{"Date":"2008-01-30T00:00:00.000","Headline":"Black Box, Dover, Harmonic, Sprint, Unisys: U.S. Equity Movers","Summary":"The following is a list of companies whose shares are having unusual price changes in U.S. markets. Stock symbols are in parentheses after company names, and prices are as of 11:40 a.m. in New York."},{"Date":"2008-01-30T00:00:00.000","Headline":"Flagstar Bancorp, Keynote Systems, Steris: U.S. Equity Movers","Summary":"The following is a list of companies whose shares are having unusual price changes in U.S. markets. Stock symbols are in parentheses after company names, and prices are as of 3:15 p.m. in New York."},{"Date":"2008-01-30T00:00:00.000","Headline":"Boeing, E*Trade, Healthways, Yahoo: U.S. Equity Movers Final","Summary":"The following is a list of companies whose shares had unusual price changes in U.S. markets. Stock symbols are in parentheses after company names, and prices are as of 4 p.m. in New York."},{"Date":"2008-01-30T00:00:00.000","Headline":"Movers: MBIA, Ambac, Amazon.com, Starbucks, Yahoo, Baker Hughes","Summary":"Wednesday's stocks in the news"},{"Date":"2008-02-04T00:00:00.000","Headline":"German Stocks Gain for Second Day; TUI, MAN and BMW Shares Rise","Summary":"German stocks rose for a second day in a row as investors speculated Microsoft Corp.'s $44.6 billion unsolicited bid to buy Yahoo! Inc. may signal a revival of mergers and acquisitions."},{"Date":"2008-02-06T00:00:00.000","Headline":"Big Pharma's Patent Headache","Summary":"In 2008 more than 10 top-selling drugs will lose patent protection. The industry hopes to recoup the losses with authorized generics"},{"Date":"2008-02-12T00:00:00.000","Headline":"Bilfinger Berger, Hochtief, Norddeutsche: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses after company names, and prices are from the last close."},{"Date":"2008-02-12T00:00:00.000","Headline":"GTx: A Compelling Biotech","Summary":"S&P says the company's lead drug candidate, Acapodene, represents a \"significant opportunity\" in the treatment of prostate cancer"},{"Date":"2008-02-14T00:00:00.000","Headline":"Earnings Ahead: W. European Earnings Expected Feb. 15-Feb. 22","Summary":"The following Western European companies are expected to report earnings from Feb. 15 to Feb."},{"Date":"2008-02-15T00:00:00.000","Headline":"A Problematic Proxy Season","Summary":"Shareholders have begun flexing their muscles and are preparing to take management to task during companies' annual meetings this year"},{"Date":"2008-02-17T00:00:00.000","Headline":"Deutsche Telekom, Merck, Northern Rock: European Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Europe. Stock symbols are in parentheses after company names, and prices are from the last close."},{"Date":"2008-02-18T00:00:00.000","Headline":"Aareal, Allianz, Commerzbank, IKB, Merck: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses after company names, and prices are from the last close."},{"Date":"2008-02-18T00:00:00.000","Headline":"German Stocks Rise, Led by Deutsche Postbank; IKB Plummets","Summary":"German stocks rose, led by Deutsche Postbank AG after a report said Commerzbank AG is the government's partner of choice for a merger with the country's biggest consumer bank by clients"},{"Date":"2008-02-18T00:00:00.000","Headline":"Japan Stock Preview: Mitsui Fudosan, Sumida, Toshiba, Takeda","Summary":"The following is a list of companies whose shares may move in Japanese markets today. Stock symbols are in brackets, and prices are from the last close. The information stated in each item was released after the last close of trading, unless stated otherwise."},{"Date":"2008-03-06T00:00:00.000","Headline":"Inside Drugmakers' War on Fat","Summary":"A huge jackpot awaits the company that devises an effective fix for obesity"},{"Date":"2008-03-06T00:00:00.000","Headline":"Tech Biggies Rely on comScore","Summary":"Tiny comScore (SCOR) serves giant customers, such as AOL (TWX), Best Buy (BBY), Google (GOOG), Merck (MRK), Microsoft (MSFT), Verizon (VZ), and Yahoo! (YHOO) Why? They benefit from comScore's proprietary technology that provides customized information about Web sites and also gives demographic characteristics, attitudes, and lifestyle profiles of online customers. ComScore, for instance, was the first to detect that fewer users have been clicking on Google's search ads. Scott Wieler, CEO of Sign"},{"Date":"2008-03-06T00:00:00.000","Headline":"Drugs to Make You Thin","Summary":"An obesity therapy is the Holy Grail of the pharma industry, and a new crop of antifat medicines is making its way to the FDA. Merck (MRK) expects to release data on its obesity treatment in late March and file for approval by the end of the year. Close behind are a coterie of competitors large and small, including Pfizer (PFE), Amylin (AMLN), and Vivus (VVUS). But ensuring safety will be a supersize challenge, considering the legacy of obesity drugs' scary side effects."},{"Date":"2008-03-06T00:00:00.000","Headline":"Boards Should Scrutinize Political Spending","Summary":"Meaningful and effective oversight by directors of company contributions can help avoid investigations, fines, and indictments"},{"Date":"2008-03-11T00:00:00.000","Headline":"German Stocks Advance, Led by Metro, Postbank, E.ON, RWE Rise","Summary":"Germany's benchmark DAX Index rose for the first time in four days, led by Metro AG and Deutsche Postbank AG. E.ON AG and RWE AG, Germany's two biggest utilities, also gained."},{"Date":"2008-03-17T00:00:00.000","Headline":"Test Time for India's Drugmakers","Summary":"India's pharma companies are moving beyond generics to set their sights on the research and development of new drugs, but the risks are many"},{"Date":"2008-03-18T00:00:00.000","Headline":"Analyst Actions: Lehman Brothers, Teekay, Dynavax","Summary":"Analyst Actions: Lehman Brothers, Teekay, Dynavax"},{"Date":"2008-03-20T00:00:00.000","Headline":"What Ever Happened to 'An Apple a Day'?","Summary":"Making the case that Big Pharma is obsessed with saleseven at the risk of patients' health"},{"Date":"2008-03-31T00:00:00.000","Headline":"U.S. Equity Movers: Fortune Brands, Monsanto, Philip Morris","Summary":"The following is a list of companies whose shares are having unusual price changes in U.S. markets. Stock symbols are in parentheses after company names, and prices are as of 2:50 p.m. in New York."},{"Date":"2008-03-31T00:00:00.000","Headline":"Stocks Rise as Awful Quarter Ends","Summary":"Wall Street eyed the Treasury's financial-industry oversight plan, a stronger than expected Chicago PMI, and big drops for Merck and Schering-Plough"},{"Date":"2008-03-31T00:00:00.000","Headline":"U.S. Equity Movers: Fortune Brands, Monsanto, Philip Morris","Summary":"The following is a list of companies whose shares had unusual price changes in U.S. markets. Stock symbols are in parentheses after company names, and prices are as of 4 p.m. in New York."},{"Date":"2008-03-31T00:00:00.000","Headline":"Movers: Schering-Plough, Merck, Fairpoint, Ansoft, Citigroup, IACI","Summary":"Monday's stocks in the news"},{"Date":"2008-03-31T00:00:00.000","Headline":"Analyst Actions: Schering-Plough, Abbott Labs, Fairpoint, Methode Electronics","Summary":"Analyst Actions: Schering-Plough, Abbott Labs, Fairpoint, Methode Electronics"},{"Date":"2008-03-31T00:00:00.000","Headline":"S&P Picks and Pans: Merck, Schering-Plough, IACI, Citi, Altria","Summary":"Analyst opinions on stocks making headlines in Monday's market"},{"Date":"2008-03-31T00:00:00.000","Headline":"A Weak Prognosis for Vytorin and Zetia","Summary":"Schering-Plough and Merck will likely see plunging sales after Dr. Harlan Krumholtz advises cardiologists not to prescribe the cholesterol drugs"},{"Date":"2008-03-31T00:00:00.000","Headline":"U.S. Equity Preview: Gilat, Lee, Merck, Schering-Plough, Tibco","Summary":"The following is a list of companies whose shares may have unusual price changes in U.S. markets. Stock symbols are in parentheses after company names, and share prices are as of 7:40 a.m. in New York unless stated otherwise."},{"Date":"2008-04-03T00:00:00.000","Headline":"Cholesterol Kerfuffle","Summary":"The drugs Vytorin and Zetia are great at lowering cholesterol. But now they're lowering something else\u2014the value of the companies that co-market them, Merck (MRK) and Schering-Plough (SGP). On Mar. 31, Schering plunged 26% and Merck 14.7%, wiping out $22 billion in shareholder value. The reason: Top cardiologists at a scientific meeting recommended that the blockbuster drugs, which pulled in $5 billion last year, be used only as a last resort. A clinical trial showed that while Zetia and Vytorin"},{"Date":"2008-04-04T00:00:00.000","Headline":"Rethinking the Presentation","Summary":"These practical tips can help you improve your presentations and avoid sabotaging your business's chances of success"},{"Date":"2008-04-07T00:00:00.000","Headline":"Behind Novartis' Eye-Popping Buyout","Summary":"The Swiss drug giant's $39 billion deal for Alcon will give it fresh avenues for growth -- and further expansion into ophthalmic care"},{"Date":"2008-04-09T00:00:00.000","Headline":"German Stocks Fall for Second Day, Led by Banks, Deutsche Post","Summary":"Germany's DAX Index dropped for a second day, led by banks, as concern mounted financial-market turmoil will continue."},{"Date":"2008-04-15T00:00:00.000","Headline":"Heart Disease: Not About Cholesterol?","Summary":"AstraZenaca's Crestor study finds that statins may help prevent heart attacks because they control inflammation, not because they lower cholesterol"},{"Date":"2008-04-17T00:00:00.000","Headline":"Calendar","Summary":"Calendar"},{"Date":"2008-04-21T00:00:00.000","Headline":"Germany's DAX Index Retreats, Led by Commerzbank, BMW, Daimler","Summary":"Germany's DAX Index dropped, led by banks and carmakers, as Bank of America Corp. said profit fell for a third straight quarter and crude oil climbed to a record."},{"Date":"2008-04-21T00:00:00.000","Headline":"Stocks Finish Mixed","Summary":"Bank of America's first quarter earnings disappointed Wall Street, while National City slashed its dividend. Oil prices closed above $117, a new record"},{"Date":"2008-04-21T00:00:00.000","Headline":"Arch Coal, Circor, Cirrus, Merck, Novartis: U.S. Equity Preview","Summary":"The following companies may have unusual price changes in U.S. trading. Stock symbols are in parentheses, and share prices are as of 9 a.m. in New York unless stated otherwise."},{"Date":"2008-04-21T00:00:00.000","Headline":"S&P Picks and Pans: Bank of America, National City, Mattel, Hasbro, Merck, Eli Lilly","Summary":"Analysts' opinions on stocks in the news Monday"},{"Date":"2008-04-21T00:00:00.000","Headline":"Movers: Bank of America, National City, Apple, Merck, Eli Lilly, Mattel, Hasbro","Summary":"Monday's stocks in the news"},{"Date":"2008-04-22T00:00:00.000","Headline":"Arcandor, Ericsson, Infineon, Nestle: European Equity Preview","Summary":"The following companies may have unusual price changes in European trading. Stock symbols are in parentheses, and share prices are from the previous close."},{"Date":"2008-04-23T00:00:00.000","Headline":"Arcandor, Infineon, Merck, SGL Carbon: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses, and share prices are from the previous close."},{"Date":"2008-04-28T00:00:00.000","Headline":"Movers: Wrigley, US Airways, Ford, RadioShack, Sohu.com","Summary":"Monday's stocks in the news"},{"Date":"2008-04-28T00:00:00.000","Headline":"Stocks Finish Mixed","Summary":"Investors turned cautious as Wednesday's Fed decision loomed. The market eyed high-profile deals involving Ford and Wrigley"},{"Date":"2008-04-29T00:00:00.000","Headline":"Altria, Avon, Biogen, Genentech, XL Capital: U.S. Equity Movers","Summary":"The following companies are having unusual price changes in U.S. markets today. Stock symbols are in parentheses after company names, and prices are as of 10:10 a.m. in New York."},{"Date":"2008-04-29T00:00:00.000","Headline":"FDA Rejects Merck's Cordaptive","Summary":"Given the cholesterol-lowering drug's modest test results and unknown long-term effects, rejection by regulators may not be that surprising"},{"Date":"2008-04-29T00:00:00.000","Headline":"S&P Picks and Pans: Countrywide, Energizer, Genentech, Corning, Take-Two, Merck","Summary":"Analysts' opinions on stocks in the news Tuesday"},{"Date":"2008-04-29T00:00:00.000","Headline":"Analyst Actions: Merck, Covance, Intevac","Summary":"Analyst Actions: Merck, Covance, Intevac"},{"Date":"2008-04-29T00:00:00.000","Headline":"Stocks Finish Mixed","Summary":"Traders weighed declines in a home-price index and a consumer confidence gauge as the Fed began its two-day policy meeting"},{"Date":"2008-04-29T00:00:00.000","Headline":"Movers: Citigroup, Mastercard, Visa, Merck, Energizer, Gildan Activewear","Summary":"Tuesday's stocks in the news"},{"Date":"2008-05-01T00:00:00.000","Headline":"Winning the Board Game","Summary":"This primer offers useful, if sometimes equivocal, ideas about getting back to good-governance basics"},{"Date":"2008-05-01T00:00:00.000","Headline":"A Blow to Merck","Summary":"Analysts thought Merck's (MRK) new cholesterol drug would go down smoothly, but the FDA gagged. The agency on Apr. 28 rejected Cordaptive. The pill, a reengineered version of a natural supplement called niacin, was supposed to lower bad cholesterol (LDL) and raise the good (HDL), without the unpleasant flushing that niacin generally causes. The denial caused Merck shares to swoon by 10%. The company, however, isn't giving up: It plans to launch Cordaptive in Europe and to submit additional data"},{"Date":"2008-05-05T00:00:00.000","Headline":"Anadarko, Merck, Target, Virgin Mobile: U.S. Equity Preview","Summary":"The following companies may have unusual price changes in U.S. markets tomorrow. Stock symbols are in parentheses after company names, and prices are as of 6:30 p.m. in New York, unless stated otherwise."},{"Date":"2008-05-07T00:00:00.000","Headline":"Is U.S. Innovation Headed Offshore?","Summary":"Apparently not, even though more research and development is joining manufacturing in the shift toward low-cost nations"},{"Date":"2008-05-08T00:00:00.000","Headline":"Big Drug R&D on Campus","Summary":"With pipelines drying up, drugmakers are enlisting universities to help create new treatments"},{"Date":"2008-05-12T00:00:00.000","Headline":"BMW, Deutsche Telekom, ThyssenKrupp, TUI: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses, and share prices are from the previous close."},{"Date":"2008-05-12T00:00:00.000","Headline":"Physician, Reveal Thyself","Summary":"A report that 72% of journal articles on heart stents in 2006 failed to note who funded the research draws sharp criticism of disclosure practices"},{"Date":"2008-05-20T00:00:00.000","Headline":"Amgen, Elbit, Medtronic, Netflix, Nucor: U.S. Equity Movers","Summary":"The following companies are having unusual price changes in U.S. markets. Stock symbols are in parentheses after company names, and prices are as of 9:40 a.m. in New York."},{"Date":"2008-05-21T00:00:00.000","Headline":"Cancer's Cruel Economics","Summary":"Billions of dollars are spent developing cancer drugs, but precious few get approved. Is the FDA part of the problem?"},{"Date":"2008-05-29T00:00:00.000","Headline":"Barr Tries to Right Itself After a Stumble","Summary":"How the aggressive generic drugmaker plans to rebound from an early-May earnings blunder"},{"Date":"2008-06-09T00:00:00.000","Headline":"Movers: Lehman, Apple, WaMu, Hilb Rogal & Hobb","Summary":"Monday's stocks in the news"},{"Date":"2008-06-10T00:00:00.000","Headline":"Losing Our Lead in Innovative R&D","Summary":"A new Duke and Harvard study shows that research in China and India is getting more sophisticated much faster than the numbers let on"},{"Date":"2008-06-11T00:00:00.000","Headline":"Big Pharma's R&D Booster Shot","Summary":"In their quest to develop new drugs, Western pharmaceutical companies are increasingly teaming up with companies in China and India"},{"Date":"2008-06-27T00:00:00.000","Headline":"Marcial: U.S. Steel Is on a Roll","Summary":"Even if raw material costs keep rising, the steel titan will prove its agility and continue to benefit from strong demand around the globe"},{"Date":"2008-07-02T00:00:00.000","Headline":"The Lowdown on Strategic Investments","Summary":"This kind of cash infusion can be a boon to your small business, but beware: There can be complications"},{"Date":"2008-07-06T00:00:00.000","Headline":"BMW, Freenet, Deutsche Bank, MAN, RWE: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses after company names, and prices are from the most recent close."},{"Date":"2008-07-06T00:00:00.000","Headline":"BMW, Freenet, Deutsche Bank, MAN, RWE: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses after company names, and prices are from the most recent close."},{"Date":"2008-07-06T00:00:00.000","Headline":"TNK-BP, B&B, Deutsche Bank, Heineken: European Equity Preview","Summary":"The following companies may have unusual price changes in European trading. Stock symbols are in parentheses, and share prices are from the previous close."},{"Date":"2008-07-21T00:00:00.000","Headline":"Arthrocare, Blue Coat, Genentech, Timken: U.S. Equity Movers","Summary":"The following companies had unusual price changes in U.S. trading. Stock symbols are in parentheses, and share prices are as of 4 p.m. in New York."},{"Date":"2008-07-21T00:00:00.000","Headline":"S&P Picks and Pans: Bank of America, Genentech, Yahoo, Microsoft, Schering-Plough","Summary":"Analysts' opinions on stocks in the news Monday"},{"Date":"2008-07-21T00:00:00.000","Headline":"Movers: Bank of America, Genentech, Schering-Plough, Merck","Summary":"Stocks in the news on Monday"},{"Date":"2008-07-21T00:00:00.000","Headline":"Stocks End Lower","Summary":"An early rally in financials lost steam, while oil prices rebounded on weather concerns, pushing equities lower"},{"Date":"2008-07-21T00:00:00.000","Headline":"Japan Stocks: Properties, Mitsui High-Tec, Nikon, SBI, Zephyr","Summary":"Japan's Nikkei 225 Stock Average rose 165.31, or 1.3 percent, to 12,969.01 as of the morning close in Tokyo. The following are among the most active shares in the Japanese market today. Stock symbols are in parentheses after company names."},{"Date":"2008-07-22T00:00:00.000","Headline":"Big Pharma: What Safe Haven?","Summary":"A reputed stronghold for investors, the drugmaking sector faces increasing risks: fewer prescriptions filled, patent expirations, and FDA rejections of new drugs"},{"Date":"2008-07-22T00:00:00.000","Headline":"Vytorin: A Setback for Merck and Schering","Summary":"The pharma giants thought their jointly marketed drug could be proved a stronger cholesterol fighter. But a second clinical trial also yields poor results"},{"Date":"2008-07-22T00:00:00.000","Headline":"Apple, JetBlue, Merck, Millicom, Waters: U.S. Equity Movers","Summary":"The following companies are having unusual price changes in U.S. markets. Stock symbols are in parentheses after company names, and prices are as of 10:20 a.m. in New York."},{"Date":"2008-07-22T00:00:00.000","Headline":"Movers: Apple, Wachovia, American Express, Texas Instruments, SanDisk","Summary":"Stocks on the move on Tuesday"},{"Date":"2008-07-22T00:00:00.000","Headline":"North and South American Stock Rating Changes, New Coverage","Summary":"The following is a list of North and South American stocks on which analysts changed their ratings or began coverage today. The table is sorted by firm alphabetically and by stock ticker.  Data is compiled thru firm releases."},{"Date":"2008-07-22T00:00:00.000","Headline":"AMR, Merck, SanDisk, UnitedHealth, Wachovia: U.S. Equity Movers","Summary":"The following companies had unusual price changes in U.S. markets. Stock symbols are in parentheses after company names, and prices are as of 4 p.m. in New York."},{"Date":"2008-07-22T00:00:00.000","Headline":"Fiat SpA, Pernod, Swiss Re, Volkswagen: European Equity Preview","Summary":"The following companies may have unusual price changes in European trading. Stock symbols are in parentheses, and share prices are from the previous close."},{"Date":"2008-07-22T00:00:00.000","Headline":"S&P Picks and Pans: Apple, Wachovia, Merck, UAL, American Express, UPS","Summary":"Analysts' opinions on stocks in the news Tuesday"},{"Date":"2008-07-23T00:00:00.000","Headline":"German Stocks Rise for Sixth Day as Oil Falls; Volkswagen Gains","Summary":"German stocks climbed for a sixth day, the longest winning streak since October, as oil prices fell and Volkswagen AG reported profit that beat analysts' estimates."},{"Date":"2008-07-23T00:00:00.000","Headline":"Fiat SpA, Pernod, Swiss Re, Volkswagen: European Equity Preview","Summary":"The following companies may have unusual price changes in European trading. Stock symbols are in parentheses, and share prices are from the previous close."},{"Date":"2008-07-23T00:00:00.000","Headline":"MAN, Merck, Post, Praktiker, Software AG: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses, and share prices are from the previous close."},{"Date":"2008-07-24T00:00:00.000","Headline":"A Blockbuster in Pain","Summary":"Still more on the pharma front: Vytorin has taken another hit. The onetime $2 billion blockbuster drug from Merck (MRK) and Schering-Plough (SGP) combines two cholesterol-lowering drugs in a single pill. But sales sank earlier this year after a study found the drug didn't slow the narrowing of arteries any more than standard cholesterol-lowering medications. Now a second trial, announced on July 21, shows that Vytorin doesn't help patients with heart-valve blockages\u2014and more people on the drug g"},{"Date":"2008-07-24T00:00:00.000","Headline":"German Stocks Fall on Lower Business Confidence; Infineon Slips","Summary":"Germany's benchmark DAX index ended its six-day advance as the country's business confidence fell the most since the Sept. 11 terrorist attacks in 2001, signaling growth is faltering in Europe's biggest economy."},{"Date":"2008-07-24T00:00:00.000","Headline":"German Stocks Fall on Lower Business Confidence; Daimler Slips","Summary":"Germany's benchmark DAX index ended its six-day advance as the country's business confidence fell the most since the Sept. 11 terrorist attacks in 2001 and Daimler AG cut its forecast for earnings this year."},{"Date":"2008-07-25T00:00:00.000","Headline":"The Implications of Health-Care Reform","Summary":"The U.S. health-care system faces many problems, which are widely publicized: the stress of an aging population and rising costs, tremendous inefficiencies, and imperfect quality"},{"Date":"2008-08-04T00:00:00.000","Headline":"Positioning Your Portfolio for Tough Times","Summary":"The worst decision investors can make is to bail from stocks at the bottom, so knowing your tolerance for pain when setting asset allocations is the key, financial planners say"},{"Date":"2008-08-08T00:00:00.000","Headline":"Colleges Explore Alternative Revenue Streams","Summary":"To supplement tuition income, colleges are looking at everything from high-demand graduate courses to real estate deals"},{"Date":"2008-08-11T00:00:00.000","Headline":"Movers: Waste Management, ITW, Calpine","Summary":"Plus more stocks making headlines in Monday's market"},{"Date":"2008-08-18T00:00:00.000","Headline":"China Techfaith, Merck, Nymex, WellCare: U.S. Equity Preview","Summary":"The following companies may have unusual price changes in U.S. markets tomorrow. Stock symbols are in parentheses after company names, and prices are as of 6 p.m. in New York, unless stated otherwise."},{"Date":"2008-08-21T00:00:00.000","Headline":"German Stocks Fall on Higher Oil; Lufthansa, Deutsche Bank Drop","Summary":"German stocks fell to a five-week low as higher oil prices damped the earnings outlook for airlines and carmakers and concern deepened that financial firms may post more credit-related losses."},{"Date":"2008-09-01T00:00:00.000","Headline":"German Stocks Decline, Led by Commerzbank, Henkel, Carmakers","Summary":"German stocks fell for the first time in three days as retail sales in Germany declined for a second month, and Commerzbank AG announced plans to buy Allianz SE's Dresdner Bank."},{"Date":"2008-09-01T00:00:00.000","Headline":"Germany's DAX Index Declines; Henkel, Commerzbank Lead Retreat","Summary":"German stocks fell for the first time in three days as a drop in retail sales weighed on consumer shares, overshadowing a drop in oil prices."},{"Date":"2008-09-02T00:00:00.000","Headline":"Movers: Regions Financial, Freddie Mac, Google, Lehman, UAL, Sciele Pharma","Summary":"Stocks in the news Tuesday"},{"Date":"2008-09-04T00:00:00.000","Headline":"Outsourcing the Drug Industry","Summary":"U.S. giants are rushing to partner with Indian and Chinese companiestapping their brainpower and saving millions of dollars in the search for breakthrough treatments"},{"Date":"2008-09-04T00:00:00.000","Headline":"Chinese Scientists Build Big Pharma Back Home","Summary":"In a reverse migration, U.S.-trained scientists are setting up biotech startups, contract-research companies, and university labs on the mainland"},{"Date":"2008-09-04T00:00:00.000","Headline":"Daimler, Volkswagen, BMW, Bayer, K+S: German Equity Preview","Summary":"The following companies may have unusual price changes in Germany. Stock symbols are in parentheses, and share prices are from the previous close."},{"Date":"2008-09-17T00:00:00.000","Headline":"Coca-Cola: A Strong Stock in Shaky Times","Summary":"Most analysts favor the beverage giant given its expansion overseas and growth in \"vitamin water\" and other noncarbonated drinks"},{"Date":"2008-09-18T00:00:00.000","Headline":"Citigroup, Hansen, Media General, Wachovia: U.S. Equity Movers","Summary":"The following companies had unusual price changes in U.S. trading. Stock symbols are in parentheses, and share prices are as of 4 p.m. in New York."},{"Date":"2008-10-03T00:00:00.000","Headline":"Why All the ImClone Interest? Its Pipeline","Summary":"Eli Lilly, hungry to bulk up in better-protected oncology drugs, outbid Bristol-Myers Squibb for Carl Icahn's hot property"},{"Date":"2008-10-06T00:00:00.000","Headline":"Stocks: Measuring the Monday Meltdown","Summary":"The big losers -- and winners -- among key stocks, sectors, and markets on Oct. 6"},{"Date":"2008-10-17T00:00:00.000","Headline":"Caterpillar, Dillard's, Merck, Schlumberger: U.S. Equity Movers","Summary":"The following companies are having unusual price changes in U.S. trading. Stock symbols are in parentheses, and share prices are as of 11:40 a.m. in New York."},{"Date":"2008-10-17T00:00:00.000","Headline":"Intuitive Surgical, Melco, Pozen, Wyeth: U.S. Equity Movers","Summary":"The following companies are having unusual price changes in U.S. trading. Stock symbols are in parentheses, and share prices are as of 1:15 p.m. in New York."},{"Date":"2008-10-22T00:00:00.000","Headline":"S&P Picks and Pans: Apple, Yahoo, Merck, E*Trade, EMC","Summary":"Plus more analyst opinions on stocks making headlines in Wednesday's market"},{"Date":"2008-10-22T00:00:00.000","Headline":"Stocks Tumble amid Economic Fears","Summary":"The S&P 500 hit its lowest level in more than five years Wednesday amid weak earnings reports and growing worries about the U.S. and world economies"},{"Date":"2008-10-23T00:00:00.000","Headline":"Now Severance Packages Are on the Chopping Block","Summary":"As the economy swoons, some companies are cutting workforcesand severance benefits"},{"Date":"2008-10-26T00:00:00.000","Headline":"Electrolux, Fiat, Lonza, Merck, TNT: European Equity Preview","Summary":"The following companies' shares may have unusual price changes in European trading. Stock symbols are in parentheses, and share prices are from the previous close."},{"Date":"2008-10-27T00:00:00.000","Headline":"Deutsche Telekom, E.ON, SAP, Volkswagen: German Equity Preview","Summary":"The following companies may have unusual price changes in Germany. Stock symbols are in parentheses and prices are from the previous close."},{"Date":"2008-11-12T00:00:00.000","Headline":"Unemployment: How to Slow the Bleeding","Summary":"In crafting a spending plan, federal officials must choose between measures that give a fast lift to the economy and those that create sustainable new jobs"},{"Date":"2008-11-20T00:00:00.000","Headline":"Movers: Citigroup, Gymboree, Limited Brands, Intuit","Summary":"Stocks in the news Thursday"},{"Date":"2008-12-04T00:00:00.000","Headline":"Movers: DuPont, AT&T, Merck, Nokia, Wal-Mart","Summary":"Stocks in the news Thursday"},{"Date":"2008-12-04T00:00:00.000","Headline":"Stocks Fall Ahead of Jobs Report","Summary":"Selling pressure picked up in the final hour of Thursday's session as traders anticipated a big payrolls drop in Friday's November employment report"},{"Date":"2008-12-09T00:00:00.000","Headline":"Movers: FedEx, Con-Way, Texas Instruments, UPS, Sony","Summary":"Stocks in the news Tuesday"},{"Date":"2008-12-10T00:00:00.000","Headline":"AIG, Greif, Palm, Merck, Navistar, Sprint: U.S. Equity Preview","Summary":"The following companies may have unusual price changes in U.S. trading tomorrow. Stock symbols are in parentheses, and share prices are as of 5:50 p.m. in New York, unless otherwise specified."},{"Date":"2008-12-18T00:00:00.000","Headline":"Adidas, Escada, Merck, Metro and Siemens: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses, and share prices are from the previous close."},{"Date":"2009-01-05T00:00:00.000","Headline":"Movers: Apple, Pharmaceutical Product Development, Walgreen","Summary":"Stocks in the news Monday"},{"Date":"2009-01-15T00:00:00.000","Headline":"Headhunters Face a Double-Edged Sword","Summary":"At the same time that companies have cut back on hiring, free networking services are gaining steam"},{"Date":"2009-01-16T00:00:00.000","Headline":"German Stocks Snap Seven-Day Loss; Deutsche Bank, Infineon Gain","Summary":"German stocks advanced for the first time in eight days as investors speculated the U.S. government\u2019s $20 billion investment in Bank of America Corp. will help stabilize the financial system."},{"Date":"2009-01-23T00:00:00.000","Headline":"German Stocks Decline; Infineon Technologies, Beiersdorf Fall","Summary":"German stocks dropped for a second day as concern deepened the global economic recession will erode corporate profits."},{"Date":"2009-01-23T00:00:00.000","Headline":"German Stocks Decline; Insurers, Infineon, Beiersdorf Retreat","Summary":"German stocks dropped for a second day as concern deepened the global economic recession will erode corporate profits."},{"Date":"2009-01-23T00:00:00.000","Headline":"German Stocks Decline; Insurers, Infineon, Beiersdorf Retreat","Summary":"German stocks dropped for a second day as concern deepened the global economic recession will erode corporate profits."},{"Date":"2009-01-23T00:00:00.000","Headline":"North and South American Stock Rating Changes, New Coverage","Summary":"The following is a list of North and South American stocks on which analysts changed their ratings or began coverage today. The table is sorted by firm alphabetically and by stock ticker.  Data is compiled thru firm releases."},{"Date":"2009-01-23T00:00:00.000","Headline":"A Pfizer-Wyeth Merger Isn't the Cure-All","Summary":"Pfizer (PFE) has been hinting for months that it was in the market for a major acquisition to bolster its sagging fortunes, and it may have found its target. The Wall Street Journal (NWS) reported on Jan. 23 that New York-based Pfizer, the world's largest drugmaker, is in talks to buy Wyeth (WYE), the ninth largest, for as much as $60 billion in stock and cash. Neither company will comment on the report, but that hasn't stopped analysts, investors, and industry bloggers from mulling over the pot"},{"Date":"2009-01-26T00:00:00.000","Headline":"Pfizer CEO: Wyeth Takeover Will Be Different","Summary":"Pfizer's (PFE) announcement on Jan. 26 that it will buy Wyeth (WYE) for $68 billion in cash and stock called up visions of past Pfizer acquisitions for many pharmaceutical executives\u2014and some of those visions resembled nightmares. But Pfizer CEO Jeffrey Kindler, who took the top job in 2006, insists the Wyeth deal is different from its earlier mega-mergers with Warner-Lambert in 2000 and Pharmacia in 2003."},{"Date":"2009-01-27T00:00:00.000","Headline":"German Stocks Decline, Led by Chemical Shares; Siemens Advances","Summary":"German stocks declined as better-than-estimated earnings at Siemens AG and an unexpected gain in business confidence failed to ease concerns the global recession will erode corporate profits."},{"Date":"2009-01-27T00:00:00.000","Headline":"German Stocks Decline, Led by Chemical Shares; Siemens Advances","Summary":"German stocks declined as better-than-estimated earnings at Siemens AG and an unexpected gain in business confidence failed to ease concerns the global recession will erode corporate profits."},{"Date":"2009-02-03T00:00:00.000","Headline":"Marcial: Why Schering-Plough Is Alluring","Summary":"Global pharmaceutical company Schering-Plough (SGP) has taken wing since Oct. 27, when its stock traded at a 52-week low of 12 a share. Some analysts expect the stock, now at 18, to fly even higher."},{"Date":"2009-02-03T00:00:00.000","Headline":"Movers: Dow Chemical, SanDisk, Motorola, UPS, D.R. Horton","Summary":"Dow Chemical (DOW) posts $0.62 fourth quarter loss per share, vs. $0.84 EPS a year ago (both exclude certain items), on 23% sales decline. Notes volume declined 17%, and was down in all operating segments, in all geographic areas, reflecting global economic downturn, de-stocking that occurred through most value chains."},{"Date":"2009-02-03T00:00:00.000","Headline":"Cameron, InterMune, Motorola, Perrigo, Tyco: U.S. Equity Movers","Summary":"Shares of the following companies are having unusual fluctuations in U.S. trading. Stock symbols are in parentheses, and prices are as of 9:55 a.m. in New York."},{"Date":"2009-02-03T00:00:00.000","Headline":"Stocks Finish Higher","Summary":"U.S. stock indexes finished higher Tuesday, led by strength in healthcare issues after  Merck & Co. (MRK) and Schering-Plough (SGP) posted favorable quarterly earnings results. Other market gainers included energy stocks, jumping in concert with a rise in crude oil futures; and homebuilders, aided by stronger-than-expected pending home sales data and a favorable earnings report from D.R. Horton (DHI) ."},{"Date":"2009-02-05T00:00:00.000","Headline":"Earnings: the Good...","Summary":"Gloom has pervaded the earnings season, but sunlight has shone through here and there. Standouts include some big pharma outfits, such as Merck (MRK), which on Feb. 3 said it made $1.6 billion in the fourth quarter, and Schering-Plough, which showed $442 million in black ink. Both results surprised the Street and stemmed from strenuous cost-cutting: The two have chopped 10% and 13% of their workforces, respectively. Another winner: security systems maker Tyco International (TYC), which on Feb. 3"},{"Date":"2009-02-09T00:00:00.000","Headline":"Focus Stock: Smart Buys Boost Mylan","Summary":"Mylan (MYL) has undergone a corporate metamorphosis that has transformed the company from a U.S.-only midsize generic drugmaker into the third-largest player in the over $70 billion global generics market. This has been accomplished principally through the acquisitions of the generics division of German drugmaker Merck\u2014not related to U.S.-based Merck (MRK) for $6.9 billion in October 2007 (Merck Generics); and Matrix Laboratories, an India-based manufacturer of active pharmaceutical ingredients"},{"Date":"2009-02-17T00:00:00.000","Headline":"Carlsberg, Commerzbank, Heineken, ING: European Equity Preview","Summary":"The following companies may have unusual price changes in European trading. Stock symbols are in parentheses, and share prices are from the previous close."},{"Date":"2009-02-17T00:00:00.000","Headline":"Commerzbank, Homag, Merck KGaA, Puma AG: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses, and share prices are from the previous close."},{"Date":"2009-02-23T00:00:00.000","Headline":"A Disruptive Solution for Health Care","Summary":"Encouraging adoption of new health IT tools like SimulConsult by those left out of the current hidebound system is a path toward change for all"},{"Date":"2009-02-25T00:00:00.000","Headline":"Seroquel Case: Must AstraZeneca Tell All?","Summary":"In more lawsuits, companies are being forced to reveal internal information during the pretrial discovery phase that otherwise would be kept private"},{"Date":"2009-03-09T00:00:00.000","Headline":"Merck Is Buying Schering-Plough for $41B","Summary":"The deal will help Merck bulk up its R&D pipeline and protect against patent-loss hits"},{"Date":"2009-03-09T00:00:00.000","Headline":"Stocks Finish Lower","Summary":"Traders Monday eyed more discouraging news on the global economy and credit markets, and news of the Merck-Schering Plough merger"},{"Date":"2009-03-10T00:00:00.000","Headline":"Drug Mergers: Killers for Research","Summary":"When big pharmaceutical companies merge, like  Merck and Schering-Plough or Pfizer and Wyeth, R&D always seems to suffer"},{"Date":"2009-03-10T00:00:00.000","Headline":"Stocks Soar on Citi News","Summary":"The S&P 500 jumped over 6% and the Nasdaq gained more than 7% Tuesday after word from Citigroup that it was profitable in January and February"},{"Date":"2009-03-11T00:00:00.000","Headline":"Marcial: Could J&J Make a Run at Schering-Plough?","Summary":"Its joint venture with Schering to market a hot anti-inflammatory drug is just one reason some analysts say J&J may try to outbid Merck"},{"Date":"2009-03-12T00:00:00.000","Headline":"Bank of America, Focus Media, GE, Neenah: U.S. Equity Movers","Summary":"Shares of the following companies had unusual fluctuations in U.S. trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York."},{"Date":"2009-03-12T00:00:00.000","Headline":"The Merck-Schering-Plough Deal","Summary":"What moves the market these days? Apparently not a pickup in M&A. On Mar. 9 pharmaceutical giant Merck (MRK) announced the $41 billion takeover of Schering-Plough (SGP). And while news of a big deal often spurs a rally, Merck's bid failed to improve the market's mood, and the S&P 500 slipped 1%. MF Global Re-search's Nick Kalivas says that shows how preoccupied investors are with the health of the financial system. As if to buttress his point, the S&P 500 rose 6.4% on Mar. 10 on news"},{"Date":"2009-03-12T00:00:00.000","Headline":"The Drug Mergers' Harsh Side Effects","Summary":"The recent wave of deals will solve drugmakers' short-term woes, but history shows R&D is likely to suffer"},{"Date":"2009-03-13T00:00:00.000","Headline":"Stocks Extend Rally","Summary":"Major indexes finished higher for a fourth day Friday, capping their best week in months"},{"Date":"2009-03-16T00:00:00.000","Headline":"Innovation: Singapore Is No. 1, Well Ahead of the U.S.","Summary":"For anyone interested in working in an innovative environment, the U.S. has long been the top destination. The U.S. has the culture to support innovation: the best universities, the biggest venture capital funds, the most supportive financial markets. American companies from Silicon Valley  are among the world's most inspiring success stories for entrepreneurs in China china, India india, and other emerging markets, with startup business leaders looking for inspiration to the likes of Hewlett Pa"},{"Date":"2009-03-26T00:00:00.000","Headline":"Gilead Sciences: High-Performing Pharmaceutical","Summary":"Gilead owes much of its success to making it easier for patients to comply with complex and uncomfortable drug regimens"},{"Date":"2009-04-02T00:00:00.000","Headline":"BASF, MAN, Merck KGaA, ProSiebenSat.1: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses, and share prices are from the previous close."},{"Date":"2009-04-02T00:00:00.000","Headline":"BASF SE, Bouygues, Givaudan, NH Hoteles: Europe Equity Preview","Summary":"The following companies may have unusual price changes in European trading. Stock symbols are in parentheses, and share prices are from the previous close."},{"Date":"2009-04-08T00:00:00.000","Headline":"Health Care: An Industry Checkup","Summary":"S&P Ratings says the sector's credit quality has remained steady, though some firms are more vulnerable to the weak economy"},{"Date":"2009-04-09T00:00:00.000","Headline":"ACE Grows on AIG's Woes","Summary":"Evan Greenberg, who was once in line to succeed his father at the helm of AIG, is now profiting from that company's woes as head of ACE"},{"Date":"2009-04-21T00:00:00.000","Headline":"AK Steel, DeVry, M&T Bank, New York Times: U.S. Equity Movers","Summary":"Shares of the following companies are having unusual moves in U.S. trading. Stock symbols are in parentheses, and prices are as of 10:30 a.m. in New York."},{"Date":"2009-04-21T00:00:00.000","Headline":"Stocks Finish Higher","Summary":"Banking and technology shares led the advance Tuesday as traders weighed a slew of earnings reports and testimony from Geithner"},{"Date":"2009-04-22T00:00:00.000","Headline":"IMS Health Cuts Pharma Growth Forecast","Summary":"The recession is taking a toll on growth in the pharmaceutical industry, according to a closely watched forecast by IMS Health"},{"Date":"2009-04-26T00:00:00.000","Headline":"Akzo Nobel, ING Groep, Merck, Scania: Europe Equity Preview","Summary":"The following companies may have unusual price changes in European trading. Stock symbols are in parentheses, and share prices are from the previous close."},{"Date":"2009-05-04T00:00:00.000","Headline":"Pharma: The 10 Most Promising New Drugs","Summary":"The pharmaceutical industry continues to march toward the patent cliff in 2010-2012, when a record amount of drug sales will lose patent protection in the U.S. This means some of the best-selling drugs, including Pfizer's (PFE) Lipitor, Bristol-Myers Squibb's (BMY) Plavix and Avapro, Eli Lilly's (LLY) Zyprexa, Wyeth's (WYE) Effexor, and Merck's (MRK) Cozaar\/Hyzaar and Singulair will be exposed to generic competition."},{"Date":"2009-05-04T00:00:00.000","Headline":"Marcial: Medarex, a Bright Spot in Biotech","Summary":"The world of biotechs is a tricky place for investors. Ambitious young companies aspiring to become future drug kings require huge financial resources to produce life-changing medicines that take many years to develop. Most firms never make it beyond the development stage. Nonetheless, some biotechs manage to reap enormous rewards once they reach near-commercialization of their products."},{"Date":"2009-05-08T00:00:00.000","Headline":"Marcial: Will Wal-Mart's Generics Hurt CVS and Medco?","Summary":"Will Wal-Mart (WMT) become a big headache for giant pharmacy companies CVS Caremark (CVS) and Medco Health Solutions (MHS)?"},{"Date":"2009-05-14T00:00:00.000","Headline":"How the Mighty Fall : A Primer on the Warning Signs","Summary":"In Autumn 2004, I received a phone call from Frances Hesselbein, founding president of the Leader to Leader Institute."},{"Date":"2009-05-31T00:00:00.000","Headline":"Arcandor, Hypo Real Estate, Porsche: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses, and share prices are from the previous close."},{"Date":"2009-06-04T00:00:00.000","Headline":"Research Triangle: A Model for Other Parks","Summary":"Rick L. Weddle likes to call them \"techie Tuesdays.\" As chief executive of the foundation that owns and runs North Carolina's Research Triangle Park, Weddle has been encouraging regular social mixers, with free food and drinks, where some of the park's 50,000 tech workers can mingle, network, and perhaps hatch new companies. He describes a recent gathering to celebrate Earth Day as \"the largest collection of pocket protectors and cocktails on earth.\""},{"Date":"2009-06-05T00:00:00.000","Headline":"Another Blow for Angioplasty","Summary":"Editors note: For a CBS Evening News report on angioplasty made in collaboration with BusinessWeek, click here, or go to CBS Evening News and search for angioplasty."},{"Date":"2009-06-10T00:00:00.000","Headline":"Lafley's Legacy: From Crisis to Consumer-Driven","Summary":"A.G. Lafley took the reins at Procter & Gamble (PG) during a crisis in June 2000. John Pepper, the chairman of the board, called up Lafley, who was then running P&G's beauty care division from San Francisco, and told Lafley to get on the company plane that night as he was to be named CEO the next morning. Durk Jager, Lafley's predecessor as CEO, was being ousted after 17 months for missing a series of earnings projections and failing to revive the company's competitiveness in key markets"},{"Date":"2009-06-11T00:00:00.000","Headline":"Novartis: Radically Remaking Its Drug Business","Summary":"Since its approval in 2001, Gleevec has turned a rare form of leukemia from a death sentence into a manageable disease. But with only an estimated 10,000 patients worldwide afflicted with chronic myelogenous leukemia, Novartis (NVS) initially had little interest in the drug. Dr. Brian J. Druker at Oregon Health & Science University's Knight Cancer Institute, whose lab did the basic work on Gleevec, persuaded Novartis to take a chance on it. In a 2003 Science Watch interview, Druker explains"},{"Date":"2009-06-16T00:00:00.000","Headline":"Bayer, BMW, Daimler, MLP, Rheinmetall: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses, and share prices are from the previous close."},{"Date":"2009-06-16T00:00:00.000","Headline":"Marcial: Could Medco Make an Acquisition Soon?","Summary":"Spun off by Merck (MRK) in August 2003, Medco Health Solutions (MHS) has become the largest U.S. pharmacy benefit manager (PBM), and now it may well make a large acquisition to make sure it stays ahead of the pack in the fiercely competitive but highly profitable industry."},{"Date":"2009-07-06T00:00:00.000","Headline":"Stocks Finish Mixed","Summary":"U.S. stock indexes closed mixed Monday as energy and materials issues fell in step with a drop in commodities prices while American Express (AXP) and Merck & Co. (MRK) led the blue-chip Dow industrials higher."},{"Date":"2009-07-07T00:00:00.000","Headline":"Fragile Hope for M&A","Summary":"These days, the world of mergers and acquisitions seems quiet, but below the surface there is a buzz of activity, investment bankers say."},{"Date":"2009-07-08T00:00:00.000","Headline":"Amgen's Uphill Marketing Battle","Summary":"When biotechnology giant Amgen (AMGN) announced study results for its experimental bone-loss treatment denosumab, Wall Street cheered."},{"Date":"2009-07-16T00:00:00.000","Headline":"Human Resources: They're Human, Too","Summary":"The dismal economy may be driving your HR manager to drink. That's one finding in a recent survey of 372 human resources professionals by industry publication Workforce Management. Close to a quarter of those polled said they've used alcohol, cigarettes, or recreational drugs to cope with the layoffs, pay cuts, and furloughs they must administer."},{"Date":"2009-07-21T00:00:00.000","Headline":"Continental, Infineon, Metro, Porsche: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses, and share prices are from the previous close."},{"Date":"2009-07-21T00:00:00.000","Headline":"Stocks Finish with Small Gains","Summary":"U.S. stocks closed mostly higher Tuesday, overcoming earlier profit taking to extend a winning streak into a seventh session."},{"Date":"2009-07-23T00:00:00.000","Headline":"Why Can Some Patients Get Free Drugs While Others Can't?","Summary":"Many pharmaceutical companies offer free drugs, but critics complain such Patient Assistance Programs don't go far enough"},{"Date":"2009-07-23T00:00:00.000","Headline":"Daimler, Ericsson, Fiat, Kesko, Syngenta: Europe Equity Preview","Summary":"The following companies may have unusual price changes in European trading. Stock symbols are in parentheses, and share prices are from the previous close."},{"Date":"2009-07-23T00:00:00.000","Headline":"How Real Is the Market Rally? Two Views","Summary":"With the Dow edging close to 9000, the S&P hitting a high for the year, and the Nasdaq recording its 11th consecutive advance, the question on the lips of so many investors as BusinessWeek went to press on July 22 was: Has the stock market turned a significant corner? To get a broad sense of where stocks are headed, I talked separately with two respected voices: Robert Zagunis, chairman of the investment committee at Jensen Investment Management in Lake Oswego, Ore., and Abby Joseph Cohen, s"},{"Date":"2009-07-23T00:00:00.000","Headline":"Daimler, Merck KGaA, Pfleiderer: German Equity Markets Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses, and share prices are from the previous close."},{"Date":"2009-07-26T00:00:00.000","Headline":"Mega Mergers Can't Cure the Pharmaceutical Industry","Summary":"A flurry of major pharmaceutical company mergers and acquisitions got plenty of attention this spring. Pfizer's (PFE) acquisition of Wyeth, Merck's (MRK) purchase of Schering-Plough and Genentech's (DNA) deal with Roche all made headlines for their potential to help the resulting entities reduce costs and add new, promising drugs to company pipelines."},{"Date":"2009-07-27T00:00:00.000","Headline":"BMW, Metro, Porsche, Volkswagen, RWE: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses and share prices are from the previous close."},{"Date":"2009-08-02T00:00:00.000","Headline":"Volkswagen, Lufthansa, Bayer, Daimler: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany tomorrow. Stock symbols are in parentheses and share prices are from the previous close."},{"Date":"2009-08-02T00:00:00.000","Headline":"Volkswagen, Lufthansa, Bayer, Daimler: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses and share prices are from the previous close."},{"Date":"2009-08-02T00:00:00.000","Headline":"Barclays, Daimler, E.ON, HSBC, UBS: European Equity Preview","Summary":"The following companies may be active in European trading. Stock symbols are in parentheses and share prices are from the previous close."},{"Date":"2009-08-11T00:00:00.000","Headline":"An Osteoporosis Blockbuster for Amgen?","Summary":"Editor's Note: A previous version of this story referred to an analyst from Lazard. The correct company name is Lazard Capital Markets."},{"Date":"2009-08-13T00:00:00.000","Headline":"The Buyback Boondoggle","Summary":"As the unemployment rate hovers near 10%, the economic debate is focused on how the government should aid recovery. (More stimulus spending? Tax cuts?) But it's business' task to get the economy back on track\u2014by investing in innovation and job creation. And if the recent past is any guide, corporations may stall the recovery by investing instead in something else: stock buybacks."},{"Date":"2009-08-19T00:00:00.000","Headline":"Tough Decisions on Osteoporosis Drugs","Summary":"Amgen (AMGN) and Eli Lilly (LLY) have endured some tough news in recent days on their experimental osteoporosis drugs. The companies' reactions provide investors with a clear picture of how pharmaceutical firms are adjusting their approaches to research and development in the face of a tougher, more safety-conscious Food & Drug Administration."},{"Date":"2009-08-19T00:00:00.000","Headline":"Energy, Health-Care Stocks Lead Market Higher","Summary":"U.S. stocks, closed higher Wednesday afternoon as strength in oil prices lifted the value of energy shares and helped the overall market rebound from an earlier slide. Along with energy issues, health care stocks were among the best performers."},{"Date":"2009-08-27T00:00:00.000","Headline":"Is Merck Overselling a Cancer Vaccine?","Summary":"The U.S. Food & Drug Administration is gearing up to make critical decisions about two controversial vaccines. On Sept. 9 an FDA advisory committee will consider whether Merck (MRK)'s Gardasil, given to girls to prevent cancer-causing human papilloma virus (HPV), should be approved for use in boys, who can be HPV carriers. The same panel will also advise the agency on whether it should allow a new HPV vaccine, GlaxoSmithKline (GSK)'s Cervarix, to enter the U.S. market. The FDA doesn't have t"},{"Date":"2009-08-27T00:00:00.000","Headline":"Drug, Biotech Research Spending Hangs Tough","Summary":"Corporate America's research spending shrank 4% overall, or $1.9 billion, from the fourth quarter of 2007 through the second quarter of this year, according to data compiled by Capital IQ on 961 U.S. companies. But many health-care companies have boosted their research outlays."},{"Date":"2009-09-10T00:00:00.000","Headline":"Six Sigma Makes a Comeback","Summary":"Here's one more reason why the world may face a jobless recovery: Six Sigma. In an attempt to boost earnings without putting more people on the payroll, companies are embracing the controversial data-driven system that aims to radically reduce production defects and improve processes in everything from marketing to manufacturing."},{"Date":"2009-09-18T00:00:00.000","Headline":"Stocks: The Real Post-Meltdown Victors","Summary":"A surprising number of stocks actually have boosted their market caps in the Year from Hell. An even-bigger surprise: Many are Wall Street titans"},{"Date":"2009-09-21T00:00:00.000","Headline":"Corporate M&A war chest: cash & treasury shares","Summary":"S&P Industrials (old) Cash"},{"Date":"2009-09-25T00:00:00.000","Headline":"German Stocks Fluctuate; ThyssenKrupp Falls, Beiersdorf Rises","Summary":"German stocks swung between gains and losses as U.S. durable goods orders and home sales fell short of estimates, tempering a higher-than-forecast reading on consumer confidence in the world\u2019s biggest economy."},{"Date":"2009-09-30T00:00:00.000","Headline":"Beru, MAN, Merck KGaA: German Stock Market Preview for Tomorrow","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses and prices are from the previous close."},{"Date":"2009-10-01T00:00:00.000","Headline":"Trimming Health-Care Costs Without Reforming the System","Summary":"A Kaiser Permanente study shows patients can ward off heart attacks and slash medical expenses with a simple generic drug regimen"},{"Date":"2009-10-09T00:00:00.000","Headline":"Deutsche Bank, Escada, Merck, Stada: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses, and share prices are from the previous close."},{"Date":"2009-10-27T00:00:00.000","Headline":"Bayer, Daimler, Escada, ThyssenKrupp: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses and prices are from the previous close."},{"Date":"2009-10-29T00:00:00.000","Headline":"The GDP Mirage","Summary":"Here's a riddle: If a scientist or engineer is laid off, does it affect gross domestic product?"},{"Date":"2009-11-04T00:00:00.000","Headline":"Drugmakers' Payments Draw Heat","Summary":"By Harris Meyer"},{"Date":"2009-11-16T00:00:00.000","Headline":"Devon, Genco, KHD Humboldt, Titanium Metals: U.S. Equity Movers","Summary":"Shares of the following companies are having unusual moves in U.S. trading. Stock symbols are in parentheses and share prices are as of 11 a.m. in New York."},{"Date":"2009-11-19T00:00:00.000","Headline":"Why Drugmakers Don't Twitter","Summary":"Some 60% of Americans say that when they need medical information, they turn to the Internet. At least half the group uses social networks to consult one another on symptoms, diagnoses, and treatments, according to surveys on Web behavior. Pharmaceutical companies would like to get in on the conversation, but how do these highly regulated companies twitter and friend without running afoul of federal marketing restrictions?"},{"Date":"2009-11-20T00:00:00.000","Headline":"Germany\u2019s DAX Index Advances as Volkswagen, BASF Shares Climb","Summary":"German stocks climbed, with the benchmark DAX Index extending its third straight weekly gain, as Volkswagen AG and BASF SE advanced."},{"Date":"2009-11-24T00:00:00.000","Headline":"How Big Pharma Profits from Swine Flu","Summary":"Swiss pharmaceutical giant Novartis gave U.S. efforts to combat pandemic influenzas a boost with the Nov. 24 opening of the country's first large-scale cell-culture manufacturing plant. Located in Holly Springs, N.C., the Novartis plant, backed by $487 million in federal funding, represents a major milestone in using biotech production technologies to replace the 50-year-old manufacturing process based on growing vaccines in eggs. \"This technology has the potential to leapfrog the traditional eg"},{"Date":"2009-11-25T00:00:00.000","Headline":"Can Roche Leave Genentech Alone?","Summary":"Pascal Soriot, a senior executive with Roche (RHHBY), says he was wracked with anxiety while boarding a plane from Basel, Switzerland, to San Francisco last March. The Swiss pharmaceutical giant had just acquired its longtime drug development partner, Genentech, and Soriot was on his way to meet the company's CEO, Arthur D. Levinson, credited with building one of the world's most effective pipeline for cancer drugs. The Genentech products that Roche sold overseas, including Herceptin for breast"},{"Date":"2009-12-01T00:00:00.000","Headline":"ExpressJet, Intuit, McDonald\u2019s, Santarus: U.S. Equity Preview","Summary":"Shares of the following companies may have unusual moves in U.S. trading tomorrow. Stock symbols are in parentheses, and prices are as of 5:30 p.m. in New York."},{"Date":"2009-12-02T00:00:00.000","Headline":"Stocks on the Move: AMR, UAL, Ciena, Walgreen","Summary":"Plus more stocks making headlines in Wednesday's market"},{"Date":"2009-12-03T00:00:00.000","Headline":"Biotest, Hochtief, Merck May Move: German Equity Market Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses, and share prices are from the previous close."},{"Date":"2009-12-10T00:00:00.000","Headline":"The New Prominence of Comparative Drug Trials","Summary":"Roche announced on Dec. 2 that its experimental diabetes drug performed better in a trial than Merck's (MRK) $2 billion-a-year blockbuster Januvia. This gave the Swiss giant potent bragging rights\u2014and it was part of a pattern. Six weeks earlier, Roche trumpeted data showing its treatment was superior to a diabetes drug from Eli Lilly (LLY). Next year it will wrap up two more trials, pitting its drug against diabetes products from sanofi-aventis (SNY) and Japan's Takeda."},{"Date":"2009-12-17T00:00:00.000","Headline":"Stronger Bones Build Resistance","Summary":"Two separate studies discussed at the symposium showed that bone-building drugs such as Merck's (MRK) Fosamax, Novartis' (NVS)s Zometa, and Roche's Boniva may cut older women's risk of breast cancer. One paper, drawing on data from the ongoing Women's Health Initiative, a large study backed by the federal government, showed that postmenopausal women taking either Fosamax or another drug in the same class had a 32% lower rate of developing breast cancer. A smaller Israeli trial found a 29% reduct"},{"Date":"2009-12-22T00:00:00.000","Headline":"Court Tells Microsoft to Edit Word","Summary":"Microsoft Corp. (MSFT), the world's biggest software maker, must alter its popular Word software or stop selling the product after it lost its appeal of a $200 million patent-infringement verdict won by a Canadian company."},{"Date":"2009-12-23T00:00:00.000","Headline":"America's Cup Innovation May Lift All Boats","Summary":"The America's Cup boats that will race in February\u2014products of a technological showdown between billionaire sailors\u2014may bring wings, ultralight hulls, and computers to the next generation of sailboats. The two-year legal battle between billionaires Larry Ellison of Oracle (ORCL) and Ernesto Bertarelli, who sold his family's Swiss biotech business to Merck (MRK) for $13.3 billion in 2007, has produced two racing yachts that are a decade ahead of any boat built previously, even as the legal tussle"},{"Date":"2009-12-23T00:00:00.000","Headline":"Arena Pharmaceuticals, Merrimac, Omnicare: U.S. Equity Preview","Summary":"Shares of the following companies may have unusual moves in U.S. trading tomorrow. Stock symbols are in parentheses, and prices are as of 5:20 p.m. in New York."},{"Date":"2009-12-27T00:00:00.000","Headline":"Fiat, Nestle, Seat, Telefonica, Unipol: European Equity Preview","Summary":"The following companies may be active in European trading. Stock symbols are in parentheses and share prices are from the last close."},{"Date":"2009-12-27T00:00:00.000","Headline":"Life Science Stocks: A Growing Market in 2010","Summary":"It took more than four years, a double mastectomy, and multiple other surgeries\u2014as well as radiation treatments and bad reactions to ineffective chemotherapy drugs\u2014before Christine Hanson's breast cancer was brought under control by Dr. Mark Fesen in Hutchinson, Kan. By then, cancer had spread to her lungs, liver, and brain."},{"Date":"2010-01-04T00:00:00.000","Headline":"Senate Has Edge in Final Health-Care Bill","Summary":"Senate Democrats will have the upper hand as U.S. lawmakers return to Washington this month to confront the last major hurdle in the effort to overhaul the nation's health-care system."},{"Date":"2010-01-07T00:00:00.000","Headline":"Multinationals on the Move","Summary":"U.S. multinationals that make a big chunk of revenue overseas returned nearly twice the gains of the overall market in 2009, according to Goldman Sachs (GS). Goldman ranked all 10 industry sectors in the Standard & Poor's 500-stock index to get a diversified list of 50 companies with the highest exposure to faster-growing foreign markets. They returned an average 51%, vs. 26% for the S&P."},{"Date":"2010-01-13T00:00:00.000","Headline":"Stock Picks: Google, Yahoo, Merck","Summary":"Google (GOOG)"},{"Date":"2010-01-13T00:00:00.000","Headline":"North and South American Stock Rating Changes, New Coverage","Summary":"The following is a list of North and South American stocks on which analysts changed their ratings or began coverage today. The table is sorted by firm alphabetically and by stock ticker.  Data is compiled thru firm releases."},{"Date":"2010-01-15T00:00:00.000","Headline":"Picks of the Week: Intel, Merck, RIM, Tyson","Summary":"Notable Wall Street analyst opinions on stocks in the news for the week of Jan. 11-Jan. 15:"},{"Date":"2010-01-20T00:00:00.000","Headline":"North and South American Stock Rating Changes, New Coverage","Summary":"The following is a list of North and South American stocks on which analysts changed their ratings or began coverage today. The table is sorted by firm alphabetically and by stock ticker.  Data is compiled thru firm releases."},{"Date":"2010-01-21T00:00:00.000","Headline":"Aragon, Bayer, Merck, Metro, RWE May Move: German Stock Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses, and share prices are from the previous close."},{"Date":"2010-01-31T00:00:00.000","Headline":"ABB, Danisco, Eni, Norske Skog, Vivendi: Europe Equity Preview","Summary":"The following companies\u2019 shares may be active in European trading. Stock symbols are in parentheses and share prices are from the last close."},{"Date":"2010-01-31T00:00:00.000","Headline":"Allianz, Bayer, Deutsche Bank, Lufthansa: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses, and share prices are from the previous close."},{"Date":"2010-02-22T00:00:00.000","Headline":"Commerzbank, Lufthansa, Q-Cells, Merck: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses and share prices are from the previous close."},{"Date":"2010-03-02T00:00:00.000","Headline":"AstraZeneca Chief Talks Pharma Challenges","Summary":"David Brennan is a man with many demands on his time. Not only is he chief executive of AstraZeneca (AZN), one of the world's biggest pharmaceutical companies, but the group he leads, and the industry he is part of, faces some of its biggest challenges for a generation."},{"Date":"2010-03-02T00:00:00.000","Headline":"Activision, Hertz, Merck, Novell, Verifone: U.S. Equity Preview","Summary":"Shares of the following companies may have unusual moves in U.S. trading tomorrow. Stock symbols are in parentheses, and prices are as of 6:35 p.m. in New York."},{"Date":"2010-03-07T00:00:00.000","Headline":"Bayer, Deutsche Bank, Merck, Porsche SE: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses, and share prices are from the previous close."},{"Date":"2010-03-07T00:00:00.000","Headline":"Areva, Fiat, Italcementi, Vinci, Zardoya: Europe Equity Preview","Summary":"The following companies\u2019 shares may be active in European trading. Stock symbols are in parentheses and share prices are from the last close."},{"Date":"2010-03-11T00:00:00.000","Headline":"The Quest to Boost Good Cholesterol","Summary":"Dr. Steven Nissen, 61, has built a prominent career as chief cardiologist at the Cleveland Clinic. He has run trials that helped some lifesaving drugs win approval from the Food & Drug Administration. And he voiced doubts that proved prescient about other experimental medicines."},{"Date":"2010-03-17T00:00:00.000","Headline":"Elmos, Hamburger Hafen, Merck May Move: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses and share prices are from the previous close."},{"Date":"2010-04-01T00:00:00.000","Headline":"Hospira, InterMune, Southwest, Verizon: U.S. Equity Preview","Summary":"Shares of the following companies may have unusual moves in U.S. trading on April 5. Stock symbols are in parentheses."},{"Date":"2010-04-15T00:00:00.000","Headline":"As the Pill Turns 50, a Rivalry Heats Up","Summary":"May marks the 50th anniversary of the sexual revolution sparked by a little white tablet known as the Pill. The U.S. Food & Drug Administration approved it in 1960, and the next year, German giant Bayer introduced it in Europe. Bayer profited handsomely in the ensuing decades, tweaking its contraceptive formula and extending its patents. Even in 2009\u2014with the global contraceptive market awash in cheap generics\u2014the company pulled in about $1.7 billion on its branded birth control pills, Yaz a"},{"Date":"2010-04-22T00:00:00.000","Headline":"Hugo Boss, Phoenix Solar, Praktiker: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses and share prices are from the previous close."},{"Date":"2010-04-22T00:00:00.000","Headline":"Adidas, Allianz, Fielmann, Merck: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses, and share prices are from the previous close."},{"Date":"2010-05-10T00:00:00.000","Headline":"U.S. Stock Options With Biggest Changes in Implied Volatility","Summary":"By Wendy Soong search was limited to options that are more than 10 days from expiration, have trading volume of at least 500 contracts and have strike prices within 5 percent of the underlying security's price."},{"Date":"2010-05-13T00:00:00.000","Headline":"Mobile Phones Fight Africa's Drug Wars","Summary":"While malaria is relatively easy to treat if caught early, it kills nearly 900,000 people a year, mostly in Africa. That's because across much of the continent, malaria medicine is hard to come by, and even when available, it's often fake. Although it may be years before every African has access to treatment, new technology could let anyone with a mobile phone verify that drugs are the real deal."},{"Date":"2010-05-20T00:00:00.000","Headline":"U.S. Stock Options With Biggest Changes in Implied Volatility","Summary":"By Wendy Soong search was limited to options that are more than 10 days from expiration, have trading volume of at least 500 contracts and have strike prices within 5 percent of the underlying security's price."},{"Date":"2010-05-27T00:00:00.000","Headline":"Karo Bio's Prescription: Cheaper Drug Approval","Summary":"Karo Bio, a tiny Swedish biotech company with no products on the market, has a big problem. Its experimental cholesterol-lowering pill is a potential blockbuster. But only if it can raise the $500 million needed to bankroll up to five years of large-scale testing normally required for widely used drugs that combat disease in unfamiliar ways."},{"Date":"2010-06-02T00:00:00.000","Headline":"BASF, Bayer, Merck, Porsche May Move: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses and prices are from the last close."},{"Date":"2010-06-06T00:00:00.000","Headline":"BP, Chloride, Endesa, Roche, Telefonica: Europe Equity Preview","Summary":"The following companies\u2019 shares may have unusual moves in European trading. Stock symbols are in parentheses and prices are from the last close."},{"Date":"2010-06-06T00:00:00.000","Headline":"Daimler, EADS, E.ON, Lufthansa, Merck: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses and prices are from the last close."},{"Date":"2010-06-17T00:00:00.000","Headline":"Draegerwerk, Heidelberger Druck, Merck: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses and prices are from the last close."},{"Date":"2010-06-25T00:00:00.000","Headline":"Delta, Lions Gate, Merck, Universal Health: U.S. Equity Preview","Summary":"Shares of the following companies may have unusual moves in U.S. trading on June 28. Stock symbols are in parentheses."},{"Date":"2010-06-27T00:00:00.000","Headline":"NYSE Euronext, Delta, Lions Gate, Auxilium: U.S. Equity Preview","Summary":"Shares of the following companies may have unusual moves in U.S. trading tomorrow. Stock symbols are in parentheses."},{"Date":"2010-06-29T00:00:00.000","Headline":"Merck, Puma, Societe Generale, Total: European Equity Preview","Summary":"The following companies\u2019 shares may have unusual moves in European trading. Stock symbols are in parentheses and prices are from the last close."},{"Date":"2010-07-19T00:00:00.000","Headline":"U.S. Stock Options With Biggest Changes in Implied Volatility","Summary":"By Wendy Soong search was limited to options that are more than 10 days from expiration, have trading volume of at least 500 contracts and have strike prices within 5 percent of the underlying security's price."},{"Date":"2010-07-28T00:00:00.000","Headline":"Companies in Brief","Summary":"UFC-Que Choisir, a leading consumer group in France, has joined Consumer Reports in deciding not to recommend the iPhone 4 because of problems with the device's antenna. Que Choisir reported on its website on July 27 that the antenna issue outweighs the iPhone's virtues. France is one of the most important markets for Apple (AAPL), which began selling the new handset outside the U.S. at the end of June. France Telecom is the world's second-largest iPhone carrier after AT&T."},{"Date":"2010-07-31T00:00:00.000","Headline":"Indicated Dividend Yield Rankings of S&P 500 Companies","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor's 500 Index as of today. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on the latest annual dividend paid divided by earnings."},{"Date":"2010-07-31T00:00:00.000","Headline":"Indicated Dividend Yield Ranking for the S&P 500 by Industry","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor's 500 Index by industry as of today. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on latest annual dividend paid divided by earnings. The data is first sorted by the industry name alphabetically and then by the yield in descending order. Dividends are paid on a quarterly basis unless noted."},{"Date":"2010-08-04T00:00:00.000","Headline":"Merck\u2019s Boceprevir Meets Phase 3; 2010 Submission Reaffirmed","Summary":"Merck\u2019s boceprevir (oral hepatitis C protease inhibitor) met primary endpoints in two Phase 3 trials. Reaffirms 2010 NDA. Boceprevir sales est. 2014: $424m (4 analysts). Total MRK sales est. 2014: $44.9b (8)"},{"Date":"2010-08-05T00:00:00.000","Headline":"AIDS Drugs Flow to the Third World","Summary":"Salim Abdool Karim received a standing ovation at the International AIDS Conference in Vienna last month when the South African doctor announced that a vaginal gel reduced the risk of sexual transmission of HIV to women by more than half. The advance was hailed as a breakthrough for the world's poor."},{"Date":"2010-08-23T00:00:00.000","Headline":"Qualcomm, AT&T Move in on 'M-Health'","Summary":"Qualcomm (QCOM), the mobile-phone chipmaker, and AT&T (T), the largest U.S. phone company, are angling for a piece of the emerging market for wireless devices used in providing health-related services to consumers on the go and at home."},{"Date":"2010-08-25T00:00:00.000","Headline":"Governor Chris Christie: GOP Darling","Summary":"Chris Christie is the lead actor in a new movie. It's a short film, no more than 20 minutes or so, yet its backer\u2014the Republican Governors Assn.\u2014expects to reap millions in donations from his brief appearance. The moody film features black-and-white images flashing by\u2014storm clouds, campaign rallies, and urgent news clips from election-night broadcasts. A Republican has won the governor's race in New Jersey, a Democratic stronghold, and the party of Barack Obama has been rendered powerless by his"},{"Date":"2010-08-26T00:00:00.000","Headline":"Pockets of Profit in Health-Care Stocks","Summary":"Health care has historically been a defensive sector of the stock market. It continues to underperform in an environment in which many would have predicted it would do better. This is because there's a lack of leadership in the household names: Merck (MRK), Pfizer (PFE), Johnson & Johnson (JNJ), Medtronic (MDT). In the next 6 to 12 months, none of these companies will be in the early phases of\u2014or about to engage in\u2014important new product cycles."},{"Date":"2010-08-31T00:00:00.000","Headline":"Indicated Dividend Yield Ranking for the S&P 500 by Industry","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor's 500 Index by industry as of today. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on latest annual dividend paid divided by earnings. The data is first sorted by the industry name alphabetically and then by the yield in descending order. Dividends are paid on a quarterly basis unless noted."},{"Date":"2010-08-31T00:00:00.000","Headline":"Indicated Dividend Yield Rankings of S&P 500 Companies","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor's 500 Index as of today. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on the latest annual dividend paid divided by earnings."},{"Date":"2010-09-02T00:00:00.000","Headline":"David Margolis' Fight to End AIDS","Summary":"As life goals go, David M. Margolis' is modest enough: He just wants to cure AIDS. The University of North Carolina professor has been plotting the demise of the world's deadliest infectious disease for more than a decade. Now he's planning a fresh assault with an unlikely weapon: a rarely used Merck (MRK) cancer drug."},{"Date":"2010-09-07T00:00:00.000","Headline":"Insularity: the Hidden Killer of Corporate Reputation","Summary":"Six weeks into the Deepwater Horizon disaster, as the blown oil well continued to spew crude into the Gulf of Mexico and the enormity of its damage started to become evident, BP (BP) Chief Executive Tony Hayward told reporters that no one wanted a solution to the mounting catastrophe more than he. \"I want my life back,\" he said on May 31."},{"Date":"2010-09-08T00:00:00.000","Headline":"Stock Picks: Best Buy, Bristol-Myers Squibb, MGM Resorts","Summary":"Best Buy: Janney Montgomery Scott equity analyst David Strasser reiterated a buy rating and $50 price target on shares of Best Buy (BBY) on Sept. 8."},{"Date":"2010-09-22T00:00:00.000","Headline":"Stock Picks: Adobe, eBay, Novartis","Summary":"Wall Street analysts offer buy, sell, or hold opinions on stocks in the news on Sept. 22"},{"Date":"2010-09-30T00:00:00.000","Headline":"Indicated Dividend Yield Rankings of S&P 500 Companies","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor's 500 Index as of today. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on the latest annual dividend paid divided by earnings."},{"Date":"2010-09-30T00:00:00.000","Headline":"Indicated Dividend Yield Ranking for the S&P 500 by Industry","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor's 500 Index by industry as of today. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on latest annual dividend paid divided by earnings. The data is first sorted by the industry name alphabetically and then by the yield in descending order. Dividends are paid on a quarterly basis unless noted."},{"Date":"2010-09-30T00:00:00.000","Headline":"Germany's Growth: New Rules, Old Companies","Summary":"As most developed nations stumble in the race against emerging nations, here's how Germany has succeeded in keeping skilled labor working in good jobs"},{"Date":"2010-09-30T00:00:00.000","Headline":"Individual Investors Duped by Derivatives","Summary":"Leona Miller, an 84-year-old retired beautician, says she was seeking safe and steady income from bonds two years ago when she bought securities recommended by her Wachovia (WFC) broker, Robert Baldacci, paying 9 percent interest. Within six months, Miller lost about 30 percent of her $20,000 investment, and the bonds were converted into shares of Merck (MRK) in a falling stock market. \"I just wanted him to make some money for me, like anybody else,\" says Miller, who lives in San Diego. \"I still"},{"Date":"2010-10-07T00:00:00.000","Headline":"Briefs","Summary":"Liverpool, historically England's most successful soccer club, will likely be sold to New England Sports Ventures, parent company of the Boston Red Sox, for $476 million. The sale to NESV, a Boston-based company owned by billionaire John W. Henry, is still subject to English Premier League approval and a legal challenge from Liverpool owners Tom Hicks and George Gillett, who say the offer is too low. The five-time European champion, which won the last of its 18 English league titles in 1990, was"},{"Date":"2010-10-12T00:00:00.000","Headline":"Time to Bring U.S. Corporate Profits Home","Summary":"Imagine if U.S. companies could add well over $1 trillion to their U.S. coffers in an instant without having to sell a subsidiary, issue a single share, or incur a penny of debt. While every company would no doubt use its repatriated cash differently, the windfall could fund a return of capital to shareholders through increased dividends and share buybacks. It might instead be used to repay existing debt, fund capital expenditures, or make strategic acquisitions."},{"Date":"2010-10-20T00:00:00.000","Headline":"Baader, BASF, Lufthansa, Merck, TUI: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses and share prices are from the previous close."},{"Date":"2010-10-26T00:00:00.000","Headline":"Continental, Merck, Puma, Software AG: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses and share prices are from the previous close."},{"Date":"2010-10-29T00:00:00.000","Headline":"Stock Picks: First Solar, Merck, Microsoft","Summary":"Wall Street analysts offer buy, sell, or hold opinions on stocks in the news on Oct. 29"},{"Date":"2010-10-31T00:00:00.000","Headline":"Indicated Dividend Yield Ranking for the S&P 500 by Industry","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor's 500 Index by industry as of today. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on latest annual dividend paid divided by earnings. The data is first sorted by the industry name alphabetically and then by the yield in descending order. Dividends are paid on a quarterly basis unless noted."},{"Date":"2010-10-31T00:00:00.000","Headline":"Indicated Dividend Yield Rankings of S&P 500 Companies","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor's 500 Index as of today. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on the latest annual dividend paid divided by earnings."},{"Date":"2010-11-03T00:00:00.000","Headline":"Tom Donohue: Obama's Tormentor","Summary":"Two days before Halloween, a squadron of protesters from the radical feminist group CodePink showed up in front of the headquarters of the U.S. Chamber of Commerce in Washington, D.C. The agitators, who were dressed as vampires, produced masks bearing the craggy visage of Thomas J. Donohue, the chamber's white-haired chief executive. Through the wonders of Photoshop, they had given him a wicked set of eyebrows, sharp fangs, and a red-stained mouth."},{"Date":"2010-11-21T00:00:00.000","Headline":"Dover, Dynegy, Genzyme, Merck, Time Warner: U.S. Equity Preview","Summary":"Shares of the following companies may have unusual moves in U.S. trading tomorrow. Stock symbols are in parentheses."},{"Date":"2010-11-24T00:00:00.000","Headline":"Merck May Have a Cholesterol Winner","Summary":"In 2006, Pfizer (PFE), the world's biggest drugmaker, shelved a cholesterol pill it spent $1 billion to develop after a study found the drug, called torcetrapib, raised blood pressure and actually caused more heart attacks. Pfizer's decision left rival Merck (MRK) with a tough call. Merck had also spent years pursuing a new drug that would boost the good cholesterol that ferries fat out of the bloodstream while at the same time reducing bad cholesterol."},{"Date":"2010-11-25T00:00:00.000","Headline":"Centrotherm, Commerzbank, E.ON, Merck: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses and share prices are from the previous close."},{"Date":"2010-11-26T00:00:00.000","Headline":"KWS Saat, Merck KGaA, Puma, Symrise: German Stock Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany today. Stock symbols are in parentheses and share prices are from the previous close."},{"Date":"2010-11-30T00:00:00.000","Headline":"Indicated Dividend Yield Rankings of S&P 500 Companies","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor's 500 Index as of today. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on the latest annual dividend paid divided by earnings."},{"Date":"2010-11-30T00:00:00.000","Headline":"Indicated Dividend Yield Ranking for the S&P 500 by Industry","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor's 500 Index by industry as of today. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on latest annual dividend paid divided by earnings. The data is first sorted by the industry name alphabetically and then by the yield in descending order. Dividends are paid on a quarterly basis unless noted."},{"Date":"2010-12-01T00:00:00.000","Headline":"Aeropostale, Krispy Kreme, Merck, Regal: U.S. Equity Preview","Summary":"Shares of the following companies may have unusual moves in U.S. trading tomorrow. Stock symbols are in parentheses, and prices are as of 5 p.m. in New York."},{"Date":"2010-12-01T00:00:00.000","Headline":"Briefs","Summary":"Roche, Bristol-Myers Squibb China is slashing the price of drugs made by Roche, Bristol-Myers Squibb, (BMY) and other pharma companies by about a third as the government seeks to rein in health-care costs and cool inflation. Research group IMS Health forecasts that Chinaos pharmaceutical market will expand at least 25 percent next year, spurred by a new national health insurance system designed to improve medical care. To sell broadly in China, foreign drugmakers must list their products on a go"},{"Date":"2010-12-03T00:00:00.000","Headline":"S&P 500 Companies With Weekly Estimate Revisions","Summary":"The following tables detail changes in consensus estimates for companies in the Standard & Poor\u2019s 500 Index. The tables include estimates for the fourth and first quarter. Earnings estimates are provided by Bloomberg."},{"Date":"2010-12-09T00:00:00.000","Headline":"S&P 500 Companies With Weekly Estimate Revisions","Summary":"The following tables detail changes in consensus estimates for companies in the Standard & Poor\u2019s 500 Index. The tables include estimates for the fourth and first quarter. Earnings estimates are provided by Bloomberg."},{"Date":"2010-12-12T00:00:00.000","Headline":"Adidas, BMW, Deutsche Boerse, Douglas: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses, and share prices are from the previous close."},{"Date":"2010-12-14T00:00:00.000","Headline":"U.S. Stock Options With Biggest Changes in Implied Volatility","Summary":"By Bloomberg News search was limited to options that are more than 10 days from expiration, have trading volume of at least 200 contracts and have strike prices within 5 percent of the underlying security's price."},{"Date":"2010-12-16T00:00:00.000","Headline":"S&P 500 Stocks Biggest Weekly Changes in Target Price","Summary":"The following tables show the biggest increases and decreases in analysts\u2019 target price, according to Bloomberg data, for companies in the Standard & Poor\u2019s 500 Index from Dec. 10."},{"Date":"2010-12-17T00:00:00.000","Headline":"Allianz, Beiersdorf, Deutsche Telekom: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses and share prices are from the previous close."},{"Date":"2010-12-29T00:00:00.000","Headline":"AstraZeneca's Risky Bet on Drug Discovery","Summary":"During a meal of beef and potatoes at AstraZeneca's (AZN) drug research center near Stockholm in October, Chief Executive Officer David Brennan grilled six drug development managers over a concern raised by a laboratory scientist. During a town hall meeting that morning, the newly recruited researcher had told Brennan he didn't have the freedom to pursue unusual ideas that he would have in academia, and Brennan wanted to know why, according to one research manager who was questioned by the boss."},{"Date":"2010-12-31T00:00:00.000","Headline":"Indicated Dividend Yield Ranking for the S&P 500 by Industry","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor's 500 Index by industry as of today. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on latest annual dividend paid divided by earnings. The data is first sorted by the industry name alphabetically and then by the yield in descending order. Dividends are paid on a quarterly basis unless noted."},{"Date":"2010-12-31T00:00:00.000","Headline":"Indicated Dividend Yield Rankings of S&P 500 Companies","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor's 500 Index as of today. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on the latest annual dividend paid divided by earnings."},{"Date":"2011-01-03T00:00:00.000","Headline":"New York Stock Exchange Short Interest as of Dec. 15","Summary":"The following is a complete listing of short interest positions on the New York Stock Exchange as of the Dec. 15 settlement date."},{"Date":"2011-01-03T00:00:00.000","Headline":"Largest NYSE Short Interest Changes as of Dec. 15","Summary":"The following are the largest short interest changes on the New York Stock Exchange as of the Dec. 15 settlement date. The table ranks the top positive changes followed by the top negative changes."},{"Date":"2011-01-04T00:00:00.000","Headline":"Employee Happiness: Zappos vs. HCL","Summary":"Should employees be happy?"},{"Date":"2011-01-12T00:00:00.000","Headline":"Stock Picks of Top Health-Care Funds","Summary":"Bought: Valeant Pharmaceuticals International (VRX), which develops drugs for central nervous system disorders and distributes generic and generic branded drugs in Latin American and Eastern Europe; HealthSpring (HS:US), a managed care provider (pictured)"},{"Date":"2011-01-13T00:00:00.000","Headline":"BioCryst, Biodel, Smith Micro, Whole Foods: U.S. Equity Movers","Summary":"Shares of the following companies had unusual moves in U.S. trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York."},{"Date":"2011-01-14T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of Jan. 14."},{"Date":"2011-01-21T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of Jan. 21."},{"Date":"2011-01-26T00:00:00.000","Headline":"Briefs","Summary":"The National Institutes of Health is pressing drugmakers to follow Pfizer's (PFE) lead and let government-backed scientists experiment with chemical compounds the companies failed to turn into drugs. Pfizer agreed last May to pay Washington University in St. Louis $22.5 million to find new applications for its discarded molecules. The pharmaceutical giant has signed similar agreements, worth up to $100 million, with seven New York medical schools. Pfizer (PFE) will share intellectual property ri"},{"Date":"2011-02-03T00:00:00.000","Headline":"U.S. Stock Options With Biggest Changes in Implied Volatility","Summary":"By Bloomberg News search was limited to options that are more than 10 days from expiration, have trading volume of at least 200 contracts and have strike prices within 5 percent of the underlying security's price."},{"Date":"2011-02-03T00:00:00.000","Headline":"The Recession Is Gone, and the CEO Could Be Next","Summary":"During a series of meetings of directors of Minneapolis-based Medtronic (MDT) in recent weeks, board members have mulled potential successors to outgoing Chief Executive Officer William A. Hawkins. Although the 56-year-old Hawkins had been in charge for just three and a half years, he announced in late December that he would retire in April. During his tenure, the medical equipment maker's stock has dropped 30 percent amid waning growth for core products such as pacemakers. Medtronic now says it"},{"Date":"2011-02-04T00:00:00.000","Headline":"U.S. Stock Options With Biggest Changes in Implied Volatility","Summary":"By Bloomberg News search was limited to options that are more than 10 days from expiration, have trading volume of at least 200 contracts and have strike prices within 5 percent of the underlying security's price."},{"Date":"2011-02-04T00:00:00.000","Headline":"S&P 500 Stocks Biggest Weekly Changes in Target Price","Summary":"The following tables show the biggest increases and decreases in analysts\u2019 target price, according to Bloomberg data, for companies in the Standard & Poor\u2019s 500 Index from Jan. 28."},{"Date":"2011-02-07T00:00:00.000","Headline":"Kahn Brothers Largest Holdings in 4th Quarter: 13F Alert","Summary":"The following are Kahn Brothers Group Inc top 10 holdings by market value as of December 31, according to a filing with the U.S. Securities and Exchange Commission on 02\/07\/2011."},{"Date":"2011-02-09T00:00:00.000","Headline":"The Year of the Metal Rabbit: China's High-Speed Rail Network","Summary":"It is now the Year of the Rabbit in China. Indeed, it is actually the Year of the Metal Rabbit, as it is a year in which the Chinese earth element Metal aligns with the Chinese zodiac symbol Rabbit, a rare occurrence that typically marks historic moments."},{"Date":"2011-02-14T00:00:00.000","Headline":"Orbimed Advisers Largest Holdings in 4th Quarter: 13F Alert","Summary":"The following are Orbimed Advisors LLC top 10 holdings by market value as of December 31, according to a filing with the U.S. Securities and Exchange Commission on 02\/14\/2011."},{"Date":"2011-02-14T00:00:00.000","Headline":"Appaloosa Management Largest Holdings in 4th Qtr: 13F Alert","Summary":"The following are Appaloosa Management L P top 10 holdings by market value as of December 31, according to a filing with the U.S. Securities and Exchange Commission on 02\/14\/2011."},{"Date":"2011-02-18T00:00:00.000","Headline":"S&P 500 Stocks Biggest Weekly Changes in Target Price","Summary":"The following tables show the biggest increases and decreases in analysts\u2019 target price, according to Bloomberg data, for companies in the Standard & Poor\u2019s 500 Index from Feb. 11."},{"Date":"2011-02-22T00:00:00.000","Headline":"Deutsche Boerse, E.ON, RWE, Merck: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses, and share prices are from the previous close."},{"Date":"2011-02-28T00:00:00.000","Headline":"Indicated Dividend Yield Rankings of S&P 500 Companies","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor's 500 Index as of today. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on the latest annual dividend paid divided by earnings."},{"Date":"2011-02-28T00:00:00.000","Headline":"Indicated Dividend Yield Ranking for the S&P 500 by Industry","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor's 500 Index by industry as of today. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on latest annual dividend paid divided by earnings. The data is first sorted by the industry name alphabetically and then by the yield in descending order. Dividends are paid on a quarterly basis unless noted."},{"Date":"2011-03-03T00:00:00.000","Headline":"Briefs","Summary":"Warner Music (WMG), which put itself up for sale in January, has received more than 10 bids, according to people with knowledge of the process. The company originally planned to sell only its music publishing unit, Warner\/Chappell, and pursue a merger with EMI, the London-based record company seized in February by Citigroup (C) because it breached debt covenants. Warner is now considering takeover offers for all or part of the company. Sony\/ATV Music Publishing (SNE), a venture between Sony, the"},{"Date":"2011-03-04T00:00:00.000","Headline":"U.S. Stock Options With Biggest Changes in Implied Volatility","Summary":"By Bloomberg News search was limited to options that are more than 10 days from expiration, have trading volume of at least 200 contracts and have strike prices within 5 percent of the underlying security's price."},{"Date":"2011-03-21T00:00:00.000","Headline":"U.S. Stock Options With Biggest Changes in Implied Volatility","Summary":"By Bloomberg News search was limited to options that are more than 10 days from expiration, have trading volume of at least 200 contracts and have strike prices within 5 percent of the underlying security's price."},{"Date":"2011-03-30T00:00:00.000","Headline":"U.S. Stock Options With Biggest Changes in Implied Volatility","Summary":"By Bloomberg News search was limited to options that are more than 10 days from expiration, have trading volume of at least 200 contracts and have strike prices within 5 percent of the underlying security's price."},{"Date":"2011-03-31T00:00:00.000","Headline":"Indicated Dividend Yield Rankings of S&P 500 Companies","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor's 500 Index as of today. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on the latest annual dividend paid divided by earnings."},{"Date":"2011-03-31T00:00:00.000","Headline":"Indicated Dividend Yield Ranking for the S&P 500 by Industry","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor's 500 Index by industry as of today. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on latest annual dividend paid divided by earnings. The data is first sorted by the industry name alphabetically and then by the yield in descending order. Dividends are paid on a quarterly basis unless noted."},{"Date":"2011-04-04T00:00:00.000","Headline":"Deutsche Bank, Merck KGaA, Siemens: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses and share prices are from the previous close."},{"Date":"2011-04-07T00:00:00.000","Headline":"Playing the Tax Break Game","Summary":"ROBERT MENENDEZ (D), New JerseyChampioned a temporary tax credit to allow small companies to offset a portion of investments in therapies to prevent and treat acute and chronic diseases. The pharmaceutical industry contributed $434,043 to his campaign and leadership PAC for the 2010 elections. Several drugmakers, including Merck (MRK) and Johnson & Johnson (JNJ), are based in New Jersey.DEBBIE STABENOW (D), MichiganSponsored a bill to give consumers a tax rebate of up to $7,500 toward the pu"},{"Date":"2011-04-10T00:00:00.000","Headline":"Air Berlin, Hannover Re, Metro, Siemens: German Equity Preview","Summary":"The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses and share prices are from the previous close."},{"Date":"2011-04-11T00:00:00.000","Headline":"Germany Daybook: Hochtief Cuts Earnings Target, CEO to Retire","Summary":"Hochtief (HOT GR) cut its forecast for 2011 earnings after its unit Leighton Holdings Ltd. said it expected to report a loss for the financial year."},{"Date":"2011-04-21T00:00:00.000","Headline":"Merck's Risky Bet on Research","Summary":"In early January, not two weeks into his job as chief executive officer of Merck (MRK), Kenneth C. Frazier got word that a safety panel had shut down a nearly completed 13,000-patient study of an experimental drug. It was vorapaxar, a blood thinner touted as the prize jewel in Merck's pipeline. Some analysts had predicted sales could reach $5 billion a year."},{"Date":"2011-05-10T00:00:00.000","Headline":"Kahn Brothers Largest Holdings in 1st Quarter: 13F Alert","Summary":"The following are Kahn Brothers Group Inc top 10 holdings by market value as of March 31, according to a filing with the U.S. Securities and Exchange Commission on 05\/10\/2011."},{"Date":"2011-05-12T00:00:00.000","Headline":"Big Pharma Bets on a Novel Cancer Cure","Summary":"Drug companies have long hawked cancer treatments that either kill tumors outright with chemotherapy or use pricey medicines to block the mutated genes that fuel cancer's growth. Recently, drugmakers including GlaxoSmithKline (GSK), Eli Lilly (LLY), and Novartis (NVS) have begun chasing a third approach: reprogramming the aberrant DNA that can turn cells cancerous in the first place."},{"Date":"2011-05-13T00:00:00.000","Headline":"Benihana, Conmed Healthcare, Merck, Siga: U.S. Equity Preview","Summary":"Shares of the following companies may have unusual moves in U.S. trading on May 16. Stock symbols are in parentheses, and prices are as of 5 p.m. in New York."},{"Date":"2011-05-16T00:00:00.000","Headline":"Orbimed Advisors LLC Holdings in 1st Quarter: 13F Alert","Summary":"The following is an analysis of Orbimed Advisors LLC as of March 31, according to a filing with the U.S. Securities and Exchange Commission on 05\/16\/2011."},{"Date":"2011-05-16T00:00:00.000","Headline":"New York State Teachers Holdings in 1st Quarter: 13F Alert","Summary":"The following is an analysis of New York State Teachers Retirement System as of March 31, according to a filing with the U.S. Securities and Exchange Commission on 05\/16\/2011."},{"Date":"2011-06-09T00:00:00.000","Headline":"Seeing Beyond the Stock Market Slump","Summary":"The Dow Jones industrial average dropped for five straight weeks through June 3, with one disappointing economic report after another. That's the longest streak of declines for the Dow in seven years. Still, the grim news is doing little to reduce bullishness among U.S. money managers and market strategists, including JPMorgan Chase's (JPM) David Kelly and Liz Ann Sonders of Charles Schwab (SCHW), who say strong profit growth and valuations that are below the historic average will lift equities"},{"Date":"2011-06-16T00:00:00.000","Headline":"When Two Cancer Drugs Are Better Than One","Summary":"Since 1998, when Roche Holding's Genentech won approval for the first of a new generation of personalized cancer medicines, drugmakers have rushed to develop compounds targeting specific genes and mutations responsible for cancer's growth. About two dozen targeted drugs have reached the market. An additional 800 medicines aimed at about 300 different genes are in development, says John Mendelsohn, president of the University of Texas MD Anderson Cancer Center. The methodology has produced some o"},{"Date":"2011-07-22T00:00:00.000","Headline":"CalPERS Holdings in 2nd Quarter: 13F Alert","Summary":"The following is an analysis of California Public Employee Retirement - CalPERS as of June 30, according to a filing with the U.S. Securities and Exchange Commission on 07\/21\/2011."},{"Date":"2011-07-28T00:00:00.000","Headline":"Implied Stock-Price Moves for U.S. Companies Reporting Results","Summary":"The following table shows the expected stock-price move for U.S. companies about to release"},{"Date":"2011-07-29T00:00:00.000","Headline":"U.S. Companies Reporting Midmorning EPS, July 29","Summary":"The following table lists the 130 U.S. companies that reported quarterly earnings today (end date of the quarter is noted in the last column). Companies are sorted alphabetically by ticker symbol."},{"Date":"2011-07-29T00:00:00.000","Headline":"Midmorning Positive EPS Surprises for U.S. Companies, July 29","Summary":"The following U.S. companies reported positive surprises or matched expectations today. This list ranks percent surprises of actual earnings to earnings estimates."},{"Date":"2011-07-29T00:00:00.000","Headline":"U.S. Companies Issuing Profit Outlooks for the Week of July 29","Summary":"The following U.S. companies provided their financial outlooks this week:"},{"Date":"2011-08-08T00:00:00.000","Headline":"Archos, Bayer, Bureau Veritas, Merck: European Equity Preview","Summary":"The following companies\u2019 shares may have unusual moves in European trading. Stock symbols are in parentheses."},{"Date":"2011-08-11T00:00:00.000","Headline":"Stevens Capital Mgmt Holdings in 2nd Quarter: 13F Alert","Summary":"The following is an analysis of Stevens Capital Management LLC as of June 30, according to a filing with the U.S. Securities and Exchange Commission on 08\/11\/2011."},{"Date":"2011-08-11T00:00:00.000","Headline":"Kahn Brothers Holdings in 2nd Quarter: 13F Alert","Summary":"The following is an analysis of Kahn Brothers Group Inc as of June 30, according to a filing with the U.S. Securities and Exchange Commission on 08\/10\/2011."},{"Date":"2011-08-12T00:00:00.000","Headline":"Korea Investment Corporation Holdings in 2nd Quarter: 13F Alert","Summary":"The following is an analysis of Korea Investment Corporation as of June 30, according to a filing with the U.S. Securities and Exchange Commission on 08\/12\/2011."},{"Date":"2011-08-15T00:00:00.000","Headline":"Orbimed Advisors Holdings in 2nd Quarter: 13F Alert","Summary":"The following is an analysis of Orbimed Advisors LLC as of June 30, according to a filing with the U.S. Securities and Exchange Commission on 08\/15\/2011."},{"Date":"2011-09-09T00:00:00.000","Headline":"Colfax, Investors, Johnson & Johnson, Merck: U.S. Equity Preview","Summary":"Shares of the following companies may have unusual moves in U.S. trading on Sept. 12. Stock symbols are in parentheses."},{"Date":"2011-09-11T00:00:00.000","Headline":"Colfax, Jarden, J&J, Merck, Transatlantic: U.S. Equity Preview","Summary":"Shares of the following companies may have unusual moves in U.S. trading tomorrow. Stock symbols are in parentheses."},{"Date":"2011-09-30T00:00:00.000","Headline":"S&P 500 Stocks Biggest Weekly Changes in Target Price","Summary":"The following tables show the biggest increases and decreases in analysts\u2019 target price, according to Bloomberg data, for companies in the Standard & Poor\u2019s 500 Index from Sept. 23."},{"Date":"2011-10-06T00:00:00.000","Headline":"Merck, Gilmartin, Vioxx\u2014and Drucker","Summary":"The management writer Jim Collins once recalled that, in the course of researching the backgrounds of some of America\u2019s greatest companies, he discovered Peter Drucker\u2019s \u201cintellectual fingerprints\u201d everywhere. Among those bearing his mark was the pharmaceutical giant Merck (MRK)."},{"Date":"2011-10-21T00:00:00.000","Headline":"S&P 500 Companies With Weekly Estimate Revisions","Summary":"The following tables detail changes in consensus for companies in the Standard & Poor\u2019s 500 Index. The tables include estimates for the third and fourth quarter. Earnings estimates are provided by Bloomberg."},{"Date":"2011-10-26T00:00:00.000","Headline":"Implied Stock-Price Moves for U.S. Companies Reporting Results","Summary":"The following table shows the expected stock-price move for U.S. companies about to release"},{"Date":"2011-10-27T00:00:00.000","Headline":"Implied Stock-Price Moves for U.S. Companies Reporting Results","Summary":"The following table shows the expected stock-price move for U.S. companies about to release"},{"Date":"2011-10-28T00:00:00.000","Headline":"U.S. Companies Issuing Profit Outlooks for the Week of Oct. 28","Summary":"The following U.S. companies provided their financial outlooks this week:"},{"Date":"2011-10-28T00:00:00.000","Headline":"U.S. Companies Issuing Profit Outlooks for Oct. 28","Summary":"The following U.S. companies provided their financial outlooks today:"},{"Date":"2011-10-28T00:00:00.000","Headline":"U.S. Companies Reporting Higher Quarterly EPS, Oct. 28","Summary":"The following U.S. companies reported higher earnings per share for their latest quarter (end date of the quarter is noted in the last column)."},{"Date":"2011-10-28T00:00:00.000","Headline":"U.S. Companies Reporting Positive EPS Surprises, Oct. 28","Summary":"The following U.S. companies reported positive surprises or matched expectations today. This list ranks percent surprises of actual earnings estimates."},{"Date":"2011-10-28T00:00:00.000","Headline":"Midmorning Positive EPS Surprises for U.S. Companies, Oct. 28","Summary":"The following U.S. companies reported positive surprises or matched expectations today. This list ranks percent surprises of actual earnings to earnings estimates."},{"Date":"2011-10-28T00:00:00.000","Headline":"U.S. Companies Reporting Earnings on Oct. 28","Summary":"The following table lists the 64 U.S. companies that reported quarterly earnings today (end date of the quarter is noted in the last column). Companies are sorted alphabetically by ticker symbol."},{"Date":"2011-10-28T00:00:00.000","Headline":"U.S. Companies Reporting Midmorning EPS, Oct. 28","Summary":"The following table lists the 110 U.S. companies that reported quarterly earnings today (end date of the quarter is noted in the last column). Companies are sorted alphabetically by ticker symbol."},{"Date":"2011-11-09T00:00:00.000","Headline":"Kahn Brothers Holdings in 3rd Quarter: 13F Alert","Summary":"The following is an analysis of Kahn Brothers Group Inc as of September 30, according to a filing with the U.S. Securities and Exchange Commission on 11\/09\/2011."},{"Date":"2011-11-10T00:00:00.000","Headline":"Winton Capital Management Holdings in 3rd Quarter: 13F Alert","Summary":"The following is an analysis of Winton Capital Management Limited as of September 30, according to a filing with the U.S. Securities and Exchange Commission on 11\/10\/2011."},{"Date":"2011-11-14T00:00:00.000","Headline":"Korea Investment Corporation Holdings in 3rd Quarter: 13F Alert","Summary":"The following is an analysis of Korea Investment Corporation as of September 30, according to a filing with the U.S. Securities and Exchange Commission on 11\/14\/2011."},{"Date":"2011-11-14T00:00:00.000","Headline":"Temasek Holdings (Private) Holdings in 3rd Qtr: 13F Alert","Summary":"The following is an analysis of Temasek Holdings (Private) Limited as of September 30, according to a filing with the U.S. Securities and Exchange Commission on 11\/14\/2011."},{"Date":"2011-11-14T00:00:00.000","Headline":"Fuller & Thaler Asset Mgmt Holdings in 3rd Quarter: 13F Alert","Summary":"The following is an analysis of Fuller & Thaler Asset Management as of September 30, according to a filing with the U.S. Securities and Exchange Commission on 11\/14\/2011."},{"Date":"2011-11-14T00:00:00.000","Headline":"Appaloosa Management Holdings in 3rd Quarter: 13F Alert","Summary":"The following is an analysis of Appaloosa Management LP as of September 30, according to a filing with the U.S. Securities and Exchange Commission on 11\/14\/2011."},{"Date":"2011-11-14T00:00:00.000","Headline":"Orbimed Advisors Holdings in 3rd Quarter: 13F Alert","Summary":"The following is an analysis of Orbimed Advisors LLC as of September 30, according to a filing with the U.S. Securities and Exchange Commission on 11\/14\/2011."},{"Date":"2011-11-23T00:00:00.000","Headline":"Barclays Plc, BMW, Merck KGaA: European Equity Preview","Summary":"The following companies\u2019 shares may have unusual moves in European trading. Stock symbols are in parentheses."},{"Date":"2012-01-31T00:00:00.000","Headline":"Implied Stock-Price Moves for U.S. Companies Reporting Results","Summary":"The following table shows the expected stock-price move for U.S. companies about to release"},{"Date":"2012-02-01T00:00:00.000","Headline":"Implied Stock-Price Moves for U.S. Companies Reporting Results","Summary":"The following table shows the expected stock-price move for U.S. companies about to release"},{"Date":"2012-02-02T00:00:00.000","Headline":"U.S. Companies Reporting Positive EPS Surprises, Feb. 2","Summary":"The following U.S. companies reported positive surprises or matched expectations today. This list ranks percent surprises of actual earnings estimates."},{"Date":"2012-02-02T00:00:00.000","Headline":"U.S. Companies Reporting Higher Quarterly EPS, Feb. 2","Summary":"The following U.S. companies reported higher earnings per share for their latest quarter (end date of the quarter is noted in the last column)."},{"Date":"2012-02-02T00:00:00.000","Headline":"U.S. Companies Reporting Earnings on Feb. 2","Summary":"The following table lists the 135 U.S. companies that reported quarterly earnings today (end date of the quarter is noted in the last column). Companies are sorted alphabetically by ticker symbol."},{"Date":"2012-02-02T00:00:00.000","Headline":"U.S. Companies Reporting Midmorning EPS, Feb. 2","Summary":"The following table lists the 22 U.S. companies that reported quarterly earnings today (end date of the quarter is noted in the last column). Companies are sorted alphabetically by ticker symbol."},{"Date":"2012-02-02T00:00:00.000","Headline":"Midmorning Positive EPS Surprises for U.S. Companies, Feb. 2","Summary":"The following U.S. companies reported positive surprises or matched expectations today. This list ranks percent surprises of actual earnings to earnings estimates."},{"Date":"2012-02-02T00:00:00.000","Headline":"U.S. Companies Issuing Profit Outlooks for Feb. 2","Summary":"The following U.S. companies provided their financial outlooks today:"},{"Date":"2012-02-03T00:00:00.000","Headline":"U.S. Companies Issuing Profit Outlooks for the Week of Feb. 3","Summary":"The following U.S. companies provided their financial outlooks this week:"},{"Date":"2012-02-03T00:00:00.000","Headline":"Depomed, Micron Technology, Zogenix Shares: U.S. Equity Preview","Summary":"Shares of the following companies may have unusual moves in U.S. trading on Feb. 6. Stock symbols are in parentheses, and prices are as of 6:16 p.m. in New York."},{"Date":"2012-02-05T00:00:00.000","Headline":"American Apparel, Micron, MetLife, TiVo: U.S. Equity Preview","Summary":"Shares of the following companies may have unusual moves in U.S. trading tomorrow. Stock symbols are in parentheses."},{"Date":"2012-03-01T00:00:00.000","Headline":"Indicated Dividend Yield Rankings of S&P 500 Company","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor\u2019s 500 Index as of today. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on the latest quarterly dividend paid divided by earnings."},{"Date":"2012-03-06T00:00:00.000","Headline":"U.S. Companies Issuing Profit Outlooks for March 6","Summary":"The following U.S. companies provided their financial outlooks today:"},{"Date":"2012-03-09T00:00:00.000","Headline":"U.S. Companies Issuing Profit Outlooks for the Week of March 9","Summary":"The following U.S. companies provided their financial outlooks this week:"},{"Date":"2012-03-22T00:00:00.000","Headline":"SWISS DAYBOOK: Baloise, Meyer Burger, Tax Treaty, SNB","Summary":"Baloise Holding reported 2011 profit of 60.8 million Swiss francs, missing estimates. Meyer Burger said full-year profit dropped 63 percent to 35.8 million francs. SNB\u2019s Jean-Pierre speaks this evening."},{"Date":"2012-04-25T00:00:00.000","Headline":"Implied Stock-Price Moves for U.S. Companies Reporting Results","Summary":"The following table shows the expected stock-price move for U.S. companies about to release"},{"Date":"2012-04-26T00:00:00.000","Headline":"Implied Stock-Price Moves for U.S. Companies Reporting Results","Summary":"The following table shows the expected stock-price move for U.S. companies about to release"},{"Date":"2012-04-27T00:00:00.000","Headline":"U.S. Companies Reporting Earnings on April 27","Summary":"The following table lists the 50 U.S. companies that reported quarterly earnings today (end date of the quarter is noted in the last column). Companies are sorted alphabetically by ticker symbol."},{"Date":"2012-04-27T00:00:00.000","Headline":"U.S. Companies Reporting Positive EPS Surprises, April 27","Summary":"The following U.S. companies reported positive surprises or matched expectations today. This list ranks percent surprises of actual earnings estimates."},{"Date":"2012-04-27T00:00:00.000","Headline":"U.S. Companies Reporting Higher Quarterly EPS, April 27","Summary":"The following U.S. companies reported higher earnings per share for their latest quarter (end date of the quarter is noted in the last column)."},{"Date":"2012-04-27T00:00:00.000","Headline":"Midmorning Positive EPS Surprises for U.S. Companies, April 27","Summary":"The following U.S. companies reported positive surprises or matched expectations today. This list ranks percent surprises of actual earnings to earnings estimates."},{"Date":"2012-04-27T00:00:00.000","Headline":"U.S. Companies Reporting Midmorning EPS, April 27","Summary":"The following table lists the 46 U.S. companies that reported quarterly earnings today (end date of the quarter is noted in the last column). Companies are sorted alphabetically by ticker symbol."},{"Date":"2012-04-29T00:00:00.000","Headline":"DCP, Exxon Mobil, GM, Home Federal, Merck: U.S. Equity Preview","Summary":"Shares of the following companies may have unusual moves in U.S. trading tomorrow. Stock symbols are in parentheses."},{"Date":"2012-05-17T00:00:00.000","Headline":"CEO Yachters: The Richest Men on the Seven Seas","Summary":"The Oracle (ORCL) CEO\u2019s BMW-Oracle team won the"},{"Date":"2012-05-29T00:00:00.000","Headline":"Performance of Bloomberg U.S. Spun-off Companies Index","Summary":"Following is a summary of the latest"},{"Date":"2012-06-04T00:00:00.000","Headline":"Performance of Bloomberg U.S. Spun-off Companies Index","Summary":"Following is a summary of the latest"},{"Date":"2012-07-25T00:00:00.000","Headline":"Implied Stock-Price Moves for U.S. Companies Reporting Results","Summary":"The following table shows the expected stock-price move for U.S. companies about to release quarterly results,"},{"Date":"2012-07-26T00:00:00.000","Headline":"Implied Stock-Price Moves for U.S. Companies Reporting Results","Summary":"The following table shows the expected stock-price move for U.S. companies about to release quarterly results,"},{"Date":"2012-07-27T00:00:00.000","Headline":"Midmorning Positive EPS Surprises for U.S. Companies, July 27","Summary":"The following U.S. companies reported positive surprises or matched expectations today. This list ranks percent surprises of actual earnings to earnings estimates."},{"Date":"2012-07-27T00:00:00.000","Headline":"U.S. Companies Reporting Midmorning EPS, July 27","Summary":"The following table lists the 59 U.S. companies that reported quarterly earnings today (end date of the quarter is noted in the last column). Companies are sorted alphabetically by ticker symbol."},{"Date":"2012-07-27T00:00:00.000","Headline":"U.S. Companies Reporting Earnings on July 27","Summary":"The following table lists the 59 U.S. companies that reported quarterly earnings today (end date of the quarter is noted in the last column). Companies are sorted alphabetically by ticker symbol."},{"Date":"2012-07-27T00:00:00.000","Headline":"U.S. Companies Reporting Positive EPS Surprises, July 27","Summary":"The following U.S. companies reported positive surprises or matched expectations today. This list ranks percent surprises of actual earnings estimates."},{"Date":"2012-07-27T00:00:00.000","Headline":"U.S. Companies Reporting Higher Quarterly EPS, July 27","Summary":"The following U.S. companies reported higher earnings per share for their latest quarter (end date of the quarter is noted in the last column)."},{"Date":"2012-08-14T00:00:00.000","Headline":"Fuller & Thaler Asset Mgmt Holdings in 2nd Quarter: 13F Alert","Summary":"The following is an analysis of Fuller & Thaler Asset Management as of Jun. 30, according to a filing with the U.S. Securities and Exchange Commission on Aug 14."},{"Date":"2012-10-11T00:00:00.000","Headline":"Indicated Dividend Yield Rankings of S&P 500 Companies","Summary":"The table below ranks indicated dividend yields of companies in Standard & Poor\u2019s 500 Index as of September 30. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on the latest annual dividend paid divided by earnings."},{"Date":"2012-11-06T00:00:00.000","Headline":"Indicated Dividend Yield Rankings of S&P 500 Companies","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor\u2019s 500 Index as of October 31. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on the latest annual dividend paid divided by earnings."},{"Date":"2012-11-06T00:00:00.000","Headline":"Indicated Dividend Yield Ranking for the S&P 500 by Industry","Summary":"The table below ranks indicated dividend yields of companies in the Standard & Poor\u2019s 500 Index by industry as of October 31. The yield is calculated by taking the latest declared dividend, annualized and divided by the stock price. Payout ratios are calculated based on latest annual dividend paid divided by earnings. The data is first sorted by the industry name alphabetically and then by the yield in descending order. Dividends are paid on a quarterly basis unless noted."},{"Date":"2012-11-14T00:00:00.000","Headline":"Orbimed Advisors LLC Holdings in 3rd Quarter: 13F Alert","Summary":"The following is an analysis of Orbimed Advisors LLC as of Sept. 30, according to a filing with the U.S. Securities and Exchange Commission on Nov 14."},{"Date":"2012-12-21T00:00:00.000","Headline":"S&P 500 Stocks Biggest Weekly Changes in Target Price","Summary":"The following tables show the biggest increases and decreases in analysts\u2019 target price, according to Bloomberg data, for companies in the Standard & Poor\u2019s 500 Index from Dec. 14."},{"Date":"2013-01-17T00:00:00.000","Headline":"The Most Expensive Product Recalls","Summary":"The cost of the Federal Aviation Administration\u2019s decision to ground U.S.-registered Boeing [BA] 787s is difficult to assess pending a review of the plane\u2019s lithium-ion batteries, widely considered to be the source of the plane's troubles. While not a \u201cproduct recall\u201d in the traditional sense, the 787 being pulled from commercial service could have a major financial impact on Boeing and its airline customers."},{"Date":"2013-02-01T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of Feb. 1."},{"Date":"2013-02-07T00:00:00.000","Headline":"B-School Billionaires","Summary":"An MBA doesn't guarantee riches, but for these B-school alumni, it didn't hurt. Each of the MBA grads (and one MBA dropout) listed in the slides that follow holds a spot on the Bloomberg Billionaires Index. Some became known for their shrewd business moves\u2014such as John Paulson, who bet against mortgage-backed securities, and Alexey Mordashov, who built Russian mining company Severstal into a multibillion-dollar conglomerate. A handful had notable family connections or inheritances, and one of th"},{"Date":"2013-02-08T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of Feb. 8."},{"Date":"2013-02-15T00:00:00.000","Headline":"S&P 500 Stocks With Biggest Gap Between Market Price, Estimate","Summary":"The following table shows the companies in the Standard & Poor\u2019s 500 Index with the biggest gaps between their stock price and analysts\u2019 average price estimates as of Feb. 15."},{"Date":"2013-03-08T00:00:00.000","Headline":"Dividend Impact to the S&P 500 Index for Week of March 12","Summary":"The following table lists companies in the S&P 500 index with ex-dividend dates during the week of March 11. The effect would lower the index by 0.773 points, based on the index closing price of 1544.26 on March 8."},{"Date":"2013-06-12T00:00:00.000","Headline":"Reported First Quarter EPS for S&P 500 Stocks as of June 12","Summary":"Following are the reported first quarter of 2013 earnings per share for companies in the Standard & Poor\u2019s 500 Index (end date of the quarter is noted in the last column). For the quarter-to-date, 498 companies out of 500 have reported their earnings. Companies are sorted alphabetically by ticker symbols."},{"Date":"2013-06-12T00:00:00.000","Headline":"EPS in the First Quarter of \u201913 for S&P 500 Stocks by Industry","Summary":"Here are the cumulative earnings per share results for the first quarter of 2013 for Standard & Poor\u2019s 500 Index stocks broken down into 24 industries. Within industries, companies are ranked by year-over-year percent changes."},{"Date":"2013-06-12T00:00:00.000","Headline":"Positive EPS Surprises for First Quarter of \u201913 for S&P 500","Summary":"Following are positive and unchanged earnings surprises for the first quarter of 2013 for companies in the Standard & Poor\u2019s 500 Index. So far, 66.7 percent (331 out of 496) of the S&P 500 have reported positive surprises, and 9.1 percent (45 out of 496) have reported zero percent surprises."},{"Date":"2013-06-12T00:00:00.000","Headline":"EPS in the First Quarter of \u201913 for S&P 500 Stocks by Sectors","Summary":"Here are the cumulative earnings per share results for the first quarter of 2013 for Standard & Poor\u2019s 500 Index stocks, broken down into ten sectors: consumer discretionary, consumer staples, energy, financial, health care, industrials, information technology, materials, telecommunication services and utilities. Within sectors, the companies are ranked by year-over-year percent changes."},{"Date":"2013-06-12T00:00:00.000","Headline":"Higher, Lower, Unchanged and Reversed EPS for S&P 500","Summary":"Here are the reported first quarter of 2013 earnings per share for companies in the Standard & Poor\u2019s 500 Index. Companies are divided by their reported year-over-year EPS differences (higher, lower, unchanged, reversals). Within groups, the companies are ranked by year-over-year percent changes."},{"Date":"2013-10-01T00:00:00.000","Headline":"Merck\u2019s Big Bet on R&D Founders, and 8,500 Job Cuts Ensue","Summary":"Executives at Merck (MRK) announced today that the second-largest U.S. drugmaker will fire 8,500 workers, as part of a broader effort to save $1 billion next year. The move reflects a tacit admission by the company that Chief Executive Officer Ken Frazier\u2019s big bet on research and development in recent years has failed to pay off."},{"Date":"2014-07-24T00:00:00.000","Headline":"U.S. PRE-MARKET MOVERS: ANGI CRUS DNKN FTNT ONVO QRE SKX TRIP","Summary":"Equity movers in early trading, with shrs traded pre-mkt: Advancers: ONVO +17.3% (238k); In Pact With JNJ Unit to Evaluate 3-D Bio-Printed Tissue VDSI +16.4% (19.6k); 2Q EPS Cont Ops 17c; Forecast Raised QRE +12.5% (35.7k); Breitburn Energy to Buy QR Energy for About $3.0b Incl. Debt FTNT +9% (2.1k); 2Q Adj. EPS, Rev. Beat Ests. SKX +8.4% (15.1k); 2Q EPS 68c, Gross Margin 45.9% FB +7.5% (6361.5k); 2Q Adj. EPS Beats, Mobile Ad Rev. 62% of Total UA +7% (124.4k); Raises Year Forecasts After 2Q Resu"},{"Date":"2014-09-05T00:00:00.000","Headline":"Bristol Sues Merck & Co. Over Patent for Immunotherapy Drug","Summary":"Bristol-Myers says Merck preparing to infringe BMY\u2019s patent for methods of treating cancer with anti-PD-1 antibodies. BMY seeking damages, lawsuit doesn\u2019t ask to block MRK sales BMY says patent was issued May 20, used in BMY\u2019s anti-PD-1 drug nivolumab Lawsuit filed yday in federal court in Wilmington, Dela. NOTE: Yday, Merck & Co. Wins FDA Approval for New Type of Cancer Drug"},{"Date":"2014-10-09T00:00:00.000","Headline":"A Place for Stock Investors to Hide From Falling Markets","Summary":"Stay invested and sleep at night."},{"Date":"2014-12-08T00:00:00.000","Headline":"Cubist Barred From Blocking Generic Cubicin Beyond 2016","Summary":"Cubist Pharmaceuticals Inc., the drugmaker being bought by Merck & Co. for $8.4 billion, lost a bid to block Hospira Inc. from offering a generic version of its top-selling Cubicin treatment for flesh-eating infections beyond 2016."},{"Date":"2015-01-12T00:00:00.000","Headline":"U.S. PRE-MARKET MOVERS: AEGR ASNA CPXX FMI LORL MWIV NPSP SNDK","Summary":"Equity movers in early trading, with shrs traded pre-mkt:"},{"Date":"2015-01-23T00:00:00.000","Headline":"Arbitrage Profit in U.S. Takeovers Pending on Jan. 23","Summary":"The following table shows the potential arbitrage profit in pending takeover bids for U.S. companies ranked by premium. Calculations are based on current share prices for the target and acquiring company and do not include future dividend payments or transaction costs. The offer per share is expressed in local currency."},{"Date":"2015-06-01T00:00:00.000","Headline":"U.S. EQUITY MOVERS: CLD CLDX CLVS HERO JPST MRTX NES OMG SINA","Summary":"Advancers include: OMG +28.1%; To Be Bought by Apollo for $34\/Shr, Premium 28% SINA +14.1%; In Pact With CEO for $456m Cash Investment TAOM +13.7%; Gets \u2018Going Private\u2019 Proposal at ~21% Premium JPST +10.2%; Handy & Harman to Pay $11\/Shr Cash for Jps HERO +8.1%; Saudi Aramco Withdraws Termination Notice for Hercules 261 Contract KTOS +7.2%; Ultra Electronics to Buy Kratos\u2019 EPD Unit for Up to $265m Cash REGI +5.9%; Upgraded at Piper Jaffray FELP +5.6%; Energy Assumed Buy at Goldman ANR +4.3%;"},{"Date":"2015-10-30T00:00:00.000","Headline":"Ackman: Valeant Strategy Difficult to Understand","Summary":""},{"Date":"2015-10-30T00:00:00.000","Headline":"Valeant to Sever Relationship With Philidor","Summary":""},{"Date":"2015-10-30T00:00:00.000","Headline":"Bill Ackman Stands With Valeant's Management","Summary":"Bill Ackman mentions on Pershing Square conference call on VRX the 10 largest settlement and judgments from 1991-2012 involving unlawful promotion of drugs and safety concerns, including cos. such as GSK, ABT, LLY, JNJ, MRK. Veritas Investment Research founding Partner Anthony Scilipoti and Bloomberg's Drew Armstrong and Julie Hyman speak on \"Bloomberg Markets.\" (Source: Bloomberg)"},{"Date":"2015-11-09T00:00:00.000","Headline":"Bloomberg\u2019s Elfin on Drug Pricing Subpoenas to MRK, LLY (Audio)","Summary":"Taking Stock with Kathleen Hays and Pimm Fox."},{"Date":"2016-11-03T00:00:00.000","Headline":"GOP Election Sweep May Help Financial, Drug Firms: Strategas","Summary":"In the event Republicans take control of House, Senate and White House on election day, their highest priority will likely be reform of corporate taxes and a move to a territorial tax system, Strategas head of policy research Dan Clifton writes in note. For investors, the big priority will be trying to understand what a President Trump means for international trade; notes presidents \"can impose tariffs by executive action\" Sets up a \"Republican Sweep\" basket of ETFs and stocks ETFs: Short S&"},{"Date":"2016-11-09T00:00:00.000","Headline":"U.S. ELECTION STREET WRAP: Biopharma M&A May Return","Summary":"Nasdaq Biotech pares gain to up 6% after rallying as much as 10% at the open after Trump election, healthcare second best performing sector after financials."},{"Date":"2016-11-09T00:00:00.000","Headline":"U.S. ELECTION STREET WRAP: Financials Surge on Trump Optimism","Summary":"Banks, financial cos. outperform as Donald Trump win may mean lighter regulation, more spending and growth, triggering higher interest rates, and more favorable view on deals, analysts say. Trump may also help student lenders, with NAVI up as much as 15%; FNMA up as much as 16% amid better odds of GSE capital retention KBW banks (BKX) up as much as 3.8% to highest intraday since Aug. 2015; all members rise Led by NYCB, ZION, FITB, RF, WFC, JPM, SIVB, CFG, HBAN, BAC KBW regional banks (KRX) up as"},{"Date":"2017-07-12T00:00:00.000","Headline":"China\u2019s New Silk Road Encroaches on U.S. Turf in Eastern Europe","Summary":"In the 19th century mansion in central Belgrade where bureaucrats plan some of Serbia\u2019s important overseas projects, 64-year-old Ivan Mrkic is busy unpacking boxes teeming with the books, research papers and maps he needs to become an instant expert on China."},{"Date":"2018-04-03T00:00:00.000","Headline":"Everyone Says to Buy the Dip, Even the White House: Taking Stock","Summary":"S&P 500 futures are seeing a slight bounce after a brutal selloff while the VIX remains elevated at ~23. We clawed back late in yesterday\u2019s session to end a shade above the February closing low of 2,581 -- this may be the new support to watch after we closed below the 200-day moving average for the first time in almost two years."},{"Date":"2018-04-16T00:00:00.000","Headline":"Awful Price Action on Banks a Bad Omen for Netflix: Taking Stock","Summary":"The gain in stock futures and the drop in crude oil is baffling some, though it seems as though the \"Mission Accomplished\" strikes in Syria are being looked at as more limited and less damaging than feared."},{"Date":"2018-04-23T00:00:00.000","Headline":"This Market Needs the FAANGs to Perform, Or Else: Taking Stock","Summary":"Stock futures are off highs with 10-year yields charging ever so closer to that 3% mark (peaked at 2.9957%). Commodities look mixed, with aluminum gaining more than 1% and Brent crude slipping back below $74 per barrel."},{"Date":"2018-05-01T00:00:00.000","Headline":"Jitters Everywhere, Especially Into Apple's Print: Taking Stock","Summary":"Stock futures are flat as the steel and aluminum tariff relief news was more or less telegraphed and earnings continue to pour in. The 10-year remains below 3% and many markets are closed for the May Day holiday."},{"Date":"2018-06-04T00:00:00.000","Headline":"Traders Smash Buy Buttons Despite No Deal on China: Taking Stock","Summary":"S&P 500 futures are near overnight highs, and if all stays the same, we are looking to open at the highest since mid-March in an attempt to break above the recent 2,700-2,740 range. Most everything is green, aside from FB (down 1.3% on an NYT report shedding light on fresh privacy worries) and NXPI Semi (falling ~3% on China concerns)."},{"Date":"2018-06-29T00:00:00.000","Headline":"Pulling Billions Out of Equities Is the New Thing: Taking Stock","Summary":"S&P futures have traded higher all morning, with impressive bounces in the global markets (China rose >2%, Europe up ~1%), though we\u2019ve been fading since Axios reported that Trump is telling advisers that he wants the U.S. to withdraw from the WTO (\"He\u2019s [threatened to withdraw] 100 times\"). The story goes on to say that his advisers do push back and a policy has never been put in place to take the idea seriously -- note that Mnuchin and Kudlow are both scheduled to appear on Fox Business"},{"Date":"2018-07-20T00:00:00.000","Headline":"Analysts Expect Drug Supplier Whiplash To Endure on Rebate Changes","Summary":"Analysts agree Trump\u2019s prescription drug plans look ugly -- but they are divided on the real financial impact of the changes on the pharmaceutical supply chain."},{"Date":"2018-07-27T00:00:00.000","Headline":"It's All About Social Media Contagion, Not FAANGs: Taking Stock","Summary":"Stock futures are holding on to their slight gains thanks to Amazon decoupling from most of its FAANG peers, though momentum gets hit from another whiff from a social media bellwether as Twitter plunges ~16% on weak monthly active user numbers."},{"Date":"2018-09-06T00:00:00.000","Headline":"Clorox Adding Detailed Ingredients To Labels","Summary":"To appeal to more conscious consumers, Clorox will begin adding detailed ingredient labels to some products https:\/\/bloom.bg\/2MRK5oB (Source: Bloomberg)"},{"Date":"2018-09-12T00:00:00.000","Headline":"Wall Street Is Throwing in the Towel on the Semis: Taking Stock","Summary":"The stock market saw nothing but red last week, and it\u2019s been the opposite so far over the past two days."},{"Date":"2018-09-24T00:00:00.000","Headline":"M&A Monday, Dip Buying Distract From Tech Wreckage: Taking Stock","Summary":"Stocks are taking a relatively modest hit on news that China scrapped talks with the U.S. just in time for tariffs from both sides to take effect. S&P futures are off lows and only down ~4 handles as the dip buyers reload, Europe\u2019s Stoxx 600 has fallen a paltry 0.2%, while several markets in Asia, including China, are closed for a holiday."},{"Date":"2018-09-26T00:00:00.000","Headline":"Merck (MRK) CEO Ken Frazier Still Has Something to Prove","Summary":"A key cancer drug has become a powerhouse under Ken Frazier's leadership, but more recent bets may decide his legacy."},{"Date":"2018-10-25T00:00:00.000","Headline":"Saving This Market May Come Down to These 4 Things: Taking Stock","Summary":"We should have seen all of this coming, no? Alarm after alarm kept ringing weeks before earnings season kicked off, with a slew of profit warnings in addition to virtually every earnings report in late September having some sort of let-down that caused shares to crater downward -- think back (way before the PPG and Fastenal blowups) to BMW, Micron, Red Hat, Nike, Conagra, FedEx, General Mills, KB Home, and seemingly every single auto-related company."},{"Date":"2018-11-14T00:00:00.000","Headline":"Here's What Funds Piled Into or Exited Last Quarter: 13F Wrap","Summary":"Facebook Inc. and NXP Semiconductors NV were among the losers as investors scoured 13F filings of top fund managers to glean trading ideas and parse out trends from the third quarter. Banks were among the winners after a big bet from Warren Buffett."},{"Date":"2019-01-03T00:00:00.000","Headline":"Here's What to Watch at the Year's Biggest Health Investor Event","Summary":"Investors, executives, analysts and traders will flock to San Francisco for the crown jewel of sell-side events at next week\u2019s annual JPMorgan Healthcare Conference."},{"Date":"2019-01-07T00:00:00.000","Headline":"How One or Two Stock Blowups Could Ruin Your Week: Taking Stock","Summary":"Macro is clearly trumping micro at the moment. Apple\u2019s uncharacteristic forecast cut could have had a devastating and lasting impact on the stock market, and probably would have if it were the only show in town."},{"Date":"2019-01-17T00:00:00.000","Headline":"`Baby Shark' FAANG Member Waits With Bated Breath: Taking Stock","Summary":"S&P futures appear to be broadly shrugging off a mini flash crash in Hong Kong that saw some stocks drop more than 75%, the second flash in as many weeks, though the last one was contained within the currency markets. Instead, it\u2019s more likely that the 11 handle dip we\u2019re seeing early is linked to a continuance from the bombshell that crushed the pop in the S&P in the last half-hour of trading Wednesday."},{"Date":"2019-02-01T00:00:00.000","Headline":"A Desperate Catalyst After Some Big Nothings: Taking Stock","Summary":"In news that should surprise no one, Thursday\u2019s big \"shocker\" was that trade officials between the U.S. and China agreed to keep talking -- a result this column went out on a \"limb\" to predict just days ago. But with that overhang now removed, equities can now focus on monthly payrolls, a desperately-needed data point to force a re-rating of the S&P that is coming up on a key technical level."},{"Date":"2020-07-31T00:00:00.000","Headline":"Robinhood Users Defy Smart Money on Tech and Win: Taking Stock","Summary":"Going against the smart money flow has been a winning strategy for Robinhood traders, at least when it comes to big tech."},{"Date":"2020-12-11T00:00:00.000","Headline":"Tesla\u2019s S&P Entry Sets Up a Departure Later Today: Taking Stock","Summary":"Since news broke a month ago that Tesla Inc. will join the S&P 500 Index, investors have been left to wonder which company will be dropped to make room for the electric car maker. That wait will be over shortly after the markets close Friday."},{"Date":"2021-03-25T00:00:00.000","Headline":"Merck (MRK) Molnupiravir Pill Could Change the Fight Against Covid","Summary":"The antiviral drug molnupiravir, still in clinical trials, would give doctors an important new treatment and a weapon against coronaviruses and future pandemics"},{"Date":"2021-11-11T00:00:00.000","Headline":"Merck (MRK), Pfizer (PFE) Covid Pills Won\u2019t End the Coronavirus Pandemic","Summary":"While new treatments from Pfizer and Merck have the potential to keep people out of the hospital, vaccines are still the best weapon for fighting Covid."},{"Date":"2021-12-08T00:00:00.000","Headline":"Covid Pill Molnupiravir vs. Ivermectin: Merck (MRK) Must Tackle Unproven Claims","Summary":"Unproven claims on social media that ivermectin is effective against coronavirus could trim demand for the drugmaker\u2019s new treatment."},{"Date":"2022-02-03T00:00:00.000","Headline":"Merck (MRK) Covid Pill Molnupiravir Fumble Gives Pfizer (PFE) $17 Billion Win","Summary":"The drugmaker shelved a 10-year-old drug that\u2019s provided a key component in its rival\u2019s coronavirus treatment."},{"Date":"2022-08-31T00:00:00.000","Headline":"Merck (MRK) Stalled Seagen (SGEN) Hunt Suggests Doubts about \u2018Magic Bullet\u2019 Tech","Summary":""},{"Date":"2022-11-16T00:00:00.000","Headline":"Ebola Shots Donated by Merck (MRK) to Be Tested on Vaccine-Resistant Strain","Summary":"Ebola vaccine that Merck & Co. donated to an international immunization group will be part of a trial testing three shots against a resistant strain of the deadly virus that\u2019s spreading in Uganda."},{"Date":"2022-11-16T00:00:00.000","Headline":"Ebola Shots Donated by Merck (MRK) to Be Tested on Vaccine-Resistant Strain","Summary":"Ebola vaccine that Merck & Co. donated to an international immunization group will be part of a trial testing three shots against a resistant strain of the deadly virus that\u2019s spreading in Uganda."},{"Date":"2022-12-30T00:00:00.000","Headline":"Merck Stock Rallies to Best Year Since 1995 on Strong Sales, Drug Data","Summary":""},{"Date":"2022-12-30T00:00:00.000","Headline":"Merck Stock Rallies to Best Year Since 1995 on Strong Sales, Drug Data","Summary":""},{"Date":"2023-01-17T00:00:00.000","Headline":"Merck (MRK) Ready to Remove Cancer-Linked Chemical from Diabetes Drugs in 2023","Summary":"Merck & Co. has discovered how its blockbuster diabetes medications have become contaminated with a potential carcinogen and believes it can resolve the problem by the end of the year."},{"Date":"2023-01-17T00:00:00.000","Headline":"Merck (MRK) Ready to Remove Cancer-Linked Chemical from Diabetes Drugs in 2023","Summary":"Merck & Co. has discovered how its blockbuster diabetes medications have become contaminated with a potential carcinogen and believes it can resolve the problem by the end of the year."},{"Date":"2023-01-25T00:00:00.000","Headline":"NYC Lumber Store Says Billionaire Is Trying to Demolish Its Home","Summary":"A small lumber store in Manhattan claims its former landlord conspired with billionaire developer John Catsimatidis to prevent the retailer from acquiring the building it occupied for six decades so that the structure could be demolished to make way for a high-end residential project."},{"Date":"2023-01-25T00:00:00.000","Headline":"NYC Lumber Store Says Billionaire Is Trying to Demolish Its Home","Summary":"A small lumber store in Manhattan claims its former landlord conspired with billionaire developer John Catsimatidis to prevent the retailer from acquiring the building it occupied for six decades so that the structure could be demolished to make way for a high-end residential project."},{"Date":"2023-02-01T00:00:00.000","Headline":"Merck\u2019s (MRK) Covid Drug Linked to Viable, Spreading Mutants, Study Says","Summary":"Merck & Co.\u2019s Covid-19 pill is giving rise to new mutations of the virus in some patients, according to a study that underscores the risk of trying to intentionally alter the pathogen\u2019s genetic code."},{"Date":"2023-02-01T00:00:00.000","Headline":"Merck\u2019s (MRK) Covid Drug Linked to Viable, Spreading Mutants, Study Says","Summary":"Merck & Co.\u2019s Covid-19 pill is giving rise to new mutations of the virus in some patients, according to a study that underscores the risk of trying to intentionally alter the pathogen\u2019s genetic code."},{"Date":"2023-02-24T00:00:00.000","Headline":"Merck\u2019s (MRK) Covid-19 Pill Gets Negative Recommendation in EU","Summary":"Merck & Co.\u2019s Covid-19 pill received a negative recommendation from a European Union regulatory committee in a blow to efforts to gain clearance for marketing the medicine in the bloc."},{"Date":"2023-02-24T00:00:00.000","Headline":"Merck\u2019s (MRK) Covid-19 Pill Gets Negative Recommendation in EU","Summary":"Merck & Co.\u2019s Covid-19 pill received a negative recommendation from a European Union regulatory committee in a blow to efforts to gain clearance for marketing the medicine in the bloc."},{"Date":"2023-04-16T00:00:00.000","Headline":"Merck-Moderna (MRK, MRNA) Vaccine Helps Keep Melanoma Patients Cancer-Free","Summary":"Adding a personalized cancer vaccine to the blockbuster drug Keytruda kept more melanoma patients in remission than the immune therapy alone, co-developers Moderna Inc. and Merck & Co. said in their first detailed presentation of a key study."},{"Date":"2023-04-16T00:00:00.000","Headline":"Merck-Moderna (MRK, MRNA) Vaccine Helps Keep Melanoma Patients Cancer-Free","Summary":"Adding a personalized cancer vaccine to the blockbuster drug Keytruda kept more melanoma patients in remission than the immune therapy alone, co-developers Moderna Inc. and Merck & Co. said in their first detailed presentation of a key study."},{"Date":"2023-07-31T00:00:00.000","Headline":"Amazon, Apple Provide Look at Consumers: US Earnings Week Ahead","Summary":"Consumer habits will come to the fore again in this week\u2019s earnings deluge, as Amazon.com Inc., Shopify Inc. and PayPal Holdings Inc. are expected to talk about online spending trends, and Apple Inc. may comment on the outlook for iPhone sales."},{"Date":"2023-07-31T00:00:00.000","Headline":"Amazon, Apple Provide Look at Consumers: US Earnings Week Ahead","Summary":"Consumer habits will come to the fore again in this week\u2019s earnings deluge, as Amazon.com Inc., Shopify Inc. and PayPal Holdings Inc. are expected to talk about online spending trends, and Apple Inc. may comment on the outlook for iPhone sales."},{"Date":"2023-08-01T00:00:00.000","Headline":"Merck (MRK) Raises 2023 Sales Forecast as Keytruda, Gardasil Vaccine Surge","Summary":"Merck & Co.\u2019s Keytruda and Gardasil soundly beat analysts\u2019 estimates for quarterly sales, driving the company\u2019s annual revenue forecast higher even as costs for its acquisition of Prometheus Biosciences Inc. led to an earnings outlook cut."},{"Date":"2023-08-01T00:00:00.000","Headline":"Merck (MRK) Raises 2023 Sales Forecast as Keytruda, Gardasil Vaccine Surge","Summary":"Merck & Co.\u2019s Keytruda and Gardasil soundly beat analysts\u2019 estimates for quarterly sales, driving the company\u2019s annual revenue forecast higher even as costs for its acquisition of Prometheus Biosciences Inc. led to an earnings outlook cut."},{"Date":"2023-08-09T00:00:00.000","Headline":"Barstool Sold High and Bought Low","Summary":"Also WeWork\u2019s decline, Yellow\u2019s equity value, Target as a securities-fraud target and a Reata M&A typo."},{"Date":"2023-08-09T00:00:00.000","Headline":"Barstool Sold High and Bought Low","Summary":"Also WeWork\u2019s decline, Yellow\u2019s equity value, Target as a securities-fraud target and a Reata M&A typo."}]